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ABSTRACT 
 
DAVID KIM: Toxicokinetic models of dermal exposure to jet fuel 
(Under the direction of Leena A. Nylander-French) 
 
 
 
    Dermal exposure to Jet-Propulsion Fuel 8 (JP-8) is prevalent in the United States Air Force.  
Although a large amount of exposure data was generated from previous occupational studies, dermal 
exposure to JP-8 was poorly characterized and quantitative estimates of the contribution of dermal 
exposure to the internal dose of JP-8 were unavailable.  To fill this data and knowledge gap, a 
controlled dermal exposure study was designed to quantify the toxicokinetic behavior of naphthalene, 
1-methyl naphthalene, 2-methyl naphthalene, decane, undecane, and dodecane.  Further, a 
toxicokinetic model was constructed; this model provided the basis for the development of a 
physiologically-based toxicokinetic (PBTK) model of dermal and inhalation exposure to JP-8.  The 
PBTK model was used to quantify the contribution of dermal exposure to the internal dose of 
naphthalene.  Results of this research suggest that the apparent human permeability coefficient is 10-
fold lower than estimates made in vitro.  Further, simulations of dermal exposure to JP-8 suggested 
that the tape-strip method can be used to differentiate exposure groups in epidemiology studies.  The 
median relative contribution of dermal exposure to the internal dose of naphthalene was 1.7% (10th 
percentile = 0.3% and 90th percentile = 6.9%).  The overall implication of these findings is that 
protection from dermal exposure to JP-8 can reduce the internal dose of naphthalene.  However, for 
most of the US Air Force personnel, the major contribution to the internal dose was from inhalation 
exposure.  The two most significant contributions to the scientific understanding of JP-8 exposures 
were (1) improved characterization of dermal exposures, and (2) quantitation of the toxicokinetic 
behavior of aromatic and aliphatic hydrocarbons.  Overall, this research has presented a new 
direction for toxicokinetic modeling human exposures to complex chemical mixtures.  This modeling 
strategy may be used to better assess the risks associated with JP-8 exposures in human 
populations. 
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CHAPTER 1 
BACKGROUND AND SIGNIFICANCE 
 
 
 
 
    Military activities require the use of hazardous chemicals, which can be emitted into the air, soil, 
and water.  These hazards present a risk to personnel, their families, and surrounding communities.  
The single largest chemical exposure found on military bases of North Atlantic Treaty Organization 
(NATO) nations is jet-propulsion fuel 8 (JP-8) (Zeiger and Smith 1998).  JP-8, which replaced JP-4, is 
less volatile and does not contain the lower molecular weight hydrocarbons found in gasoline.  As a 
result, exposure by inhalation may potentially be lower, but dermal exposure may play a more 
significant role in causing adverse health effects.  In this section, the current state of knowledge of 
dermal exposure to JP-8 is examined.  First, the local and systemic health effects of JP-8 are 
discussed briefly.  Second, a large body of literature in the area of dermal exposure assessment to 
chemicals is examined.  Specific studies of dermal exposure to JP-8 are then critiqued in the context 
of this broader picture of the literature. 
 
1.1 Health effects of dermal exposure to JP-8 
    JP-8 is composed of many hydrocarbons.  These include benzene, toluene, naphthalene, and 
aliphatic compounds such a nonane and decane (McDougal et al. 2000).  For some chemicals (e.g., 
benzene) more is known about the adverse health effects than others (e.g., dodecane).  It is 
impractical to summarize the health effects caused by each and every known component of JP-8.  In 
this section, the health effects of bulk exposure to JP-8 will be reviewed with examples drawn from 
studies of specific components of JP-8. 
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1.1.1 Metabolism of JP-8 components 
    JP-8 has been divided into aromatic and aliphatic components, using naphthalene and dodecane 
as markers of exposure to each fraction respectively (Baynes et al. 2001).  Metabolic products are 
often the compounds that cause toxicity.  The metabolism of naphthalene has been studied 
extensively (ATSDR 1995; Buckpitt and Bahnson 1986; US EPA 1998).  Primary metabolism of 
naphthalene by the cytochrome P450 monooxygenases results in naphthalene-1,2-oxide.  This 
epoxide rearranges to 1- and 2-naphthols.  The epoxide also undergoes phase II metabolism, such 
as conjugation with glucuronic acid, sulfate, or glutathione to form more water soluble compounds.  
The naphthols can be hydrated by epoxide hydrolase to form naphthalene-1,2-dihydrodiol, which 
itself can be converted to 1,2-naphthalenediol by catechol reductase.  The 1,2-naphthalenediol can 
undergo further oxidation to 1,2-naphthoquinone, and also form 1,4-naphthoquinone.  Further, 1-
naphthol can also produce 1,4-naphthoquinone.  Naphthalene metabolism has been studied in lung 
tissue (Buckpitt and Bahnson 1986) but not in the skin.  The metabolism of dodecane is not well 
characterized but is believed to undergo oxidation reaction to a ketone through an intermediate 
hydroxylation step (Subcommittee on Jet-Propulsion Fuel 8 2003). 
 
1.1.2 Local health effects 
    Dermal exposure to JP-8 has been associated with irritation and sensitization.  Skin irritation is a 
non-immune related response that is caused by direct damage to the stratum corneum of the skin.  
This can result in redness of the skin, blisters, and scales.  A common method of assessing damage 
to the skin is to measure the trans-epidermal water loss (TEWL).  TEWL is the rate at which water 
vapor is lost from the skin; this has been used to determine the efficiency of the barrier function of the 
skin (Gioia and Celleno 2002).  Damage done to the skin by chemical and/or physical agents causes 
the barrier function to be compromised, resulting in an increase of TEWL.  Exposures to skin in vitro 
have shown elevated TEWL and erythema in pigs (Singh et al. 2003).  Chemical exposures can also 
cause an immune-related response called allergic contact dermatitis.  Aliphatic and aromatic 
components of JP-8 have been shown to increase expression of IL-8, IL-1 α, TNF-α, and MCP-1α in 
in vitro systems of human epidermal keratinocytes (Babu et al. 2004; Chou et al. 2003).   
 3
1.1.3 Systemic health effects 
    The systemic health effects of dermal exposure to JP-8 are not expected to be different from 
inhalation exposure.  The immune system has been implicated as a potential target for JP-8 
exposures (Rhodes et al. 2003).  In this study, fuel system maintenance personnel had higher counts 
of white blood cells, neutrophils, and monocytes when compared to personnel in the low-exposure 
group (e.g., military police).  The effects of JP-8 exposure on the central nervous systems has also 
been investigated in US Air Force employees (Smith et al. 1997).  A significant association was found 
between JP-8 exposure and increased postural sway, suggesting subtle effects on 
vestibular/proprioception function.   
The carcinogenic potential of exposure to jet fuel in humans has been suggested from 
population-based epidemiological studies (Parent et al. 2000; Siemiatycki et al. 1987).  Siemiatycki et 
al. (1987) investigated, using a case-referent study design, the association between exposures to 12 
petroleum derived liquids and cancers among 3726 subjects living in Montreal, Canada.  The most 
relevant finding from this study was an association between jet-fuel exposure and kidney cancer, with 
an odds ratio (OR) of 3.4 [95% confidence interval (CI) = 1.5-7.6].  Other cancers associated with jet 
fuel were cancers of the colon and rectum.  Cancer of the kidneys was confirmed in a study 
conducted by Parent et al. (2000).  They used a case-control design consisting of 142 known cases 
of renal cell carcinoma, 1900 controls with cancer at other sites, and 533 population-based controls.  
Exposures were assigned using a questionnaire that asked questions about lifestyle and detailed 
descriptions of each subject’s job history.  Excess risk of renal cell cancer was associated with 
exposure to jet fuel (OR = 3.5, 95% CI = 1.4-8.7), aviation gasoline (OR = 3.5, 95% CI = 1.4-8.6), and 
jet fuel engine emissions (OR = 2.7, 95% CI = 0.9-8.1).  Odds ratios were adjusted for respondent 
status (self or proxy), age, smoking, BMI, and occupational confounders (i.e., exposures to other 
substances like butadiene, styrene, chromium etc.).  The main limitation of these epidemiological 
studies is that the exposures were assessed using self-reported information about each subject’s 
occupation, and not from occupational hygiene measurements.  Therefore, the route of exposure was 
not known and, thus, exposure assessment was subject to misclassification. 
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    Numerous other studies exist showing the relationship between exposure to jet fuel and/or 
components thereof, and effects on the respiratory tract, nervous system, liver, kidney, cardiovascular 
system, reproduction and development, and genotoxicity.  Many of these are summarized in the 
report by the subcommittee on JP-8 (Subcommittee on Jet-Propulsion Fuel 8 2003). 
 
1.2 Dermal exposure assessment 
    The three main routes of human exposure to chemicals are inhalation, ingestion, and dermal 
absorption.  In the past, exposure assessment has focused on inhalation exposures because it is 
considered the most important route of exposure.  Consequently, many studies have been conducted 
to measure inhalation exposures and to examine consequent effects both locally and systemically.  
For the most part, the dermal route of exposure has been neglected, making it difficult to assess its 
importance relative to other routes of exposure like inhalation and ingestion (Semple 2004).  Recent 
interest in dermal exposure assessment has been spawned by decreasing inhalation exposures to 
chemicals in the workplace.  Hence, it is suggested that dermal exposures may be relatively more 
important in contributing to total body burden.  This has motivated the occupational and 
environmental exposure assessment community to develop methods for understanding the process 
of dermal exposure so that dermal exposure to chemicals can be better evaluated and controlled.  
Such is the case for JP-8 on military bases.  Very few studies of JP-8 exposures in the field exist.  
This section reviews the current state of knowledge regarding the measurement of dermal exposure 
to chemicals and to JP-8.   
 
1.2.1 Conceptual model for dermal exposure assessment 
    Chemicals that deposit on the skin may undergo numerous processes that make assessment of 
exposure difficult.  These processes include washing, evaporation, storage, and penetration.  Simple 
measurement of the amount of chemical on the surface of the skin at one time-point will not capture 
the total amount of chemical deposited during a work shift, for example.  Further, the exposure 
intensity, the surface area of skin exposed, the frequency of skin washing, the presence of clothing or 
protective equipment, and repeated exposures will modify the amount of chemical exposure.  
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Consequently, the variability in dermal exposures to chemicals necessitates a framework for 
assessing exposures. 
    A conceptual model has been proposed to aid in identifying the key processes of dermal exposure 
(Schneider et al. 1999).  The model describes the transfer of contaminants among compartments, 
ultimately leading to dermal exposure.  The main compartments are the source compartment, air, 
surface contaminant layer, outer clothing contaminant layer, inner clothing contaminant layer, and 
skin contaminant layer.  The model describes the transport of the contaminant mass between 
compartments.  Conversion into concentration takes into account the mass of the outermost skin 
layer plus all other substances.  As a first approximation, this is the volume of bulk liquid for 
contaminants that have low volatility.   
 
1.2.2 Sampling methods for measuring dermal exposure 
    As in any exposure assessment, sampling instruments are required to quantify the amount of 
chemical that one is exposed to.  Preferably, the sampling instrument can accurately and precisely 
measure the intensity of exposure, and is simple enough for use in the field.  Currently, there are 
numerous methods for measuring dermal exposures; most have focused on the sampling of the skin 
contaminant layer, as defined in the conceptual model described above.   
    There is no standard instrument to employ when measuring dermal exposure to chemicals.  
Rather, instruments are chosen based on properties of the chemical, such as molecular weight, 
solubility in water, and reactivity.  The sampling instruments can be classified into three techniques 
based on surrogate skin, removal, and a fluorescent tracer (Fenske 1993).  Surrogate skin techniques 
use patch sampling or whole-body sampling.  In patch sampling, absorbent patches are placed under 
a worker’s clothing prior to exposure.  After exposure, the patches are removed and analyzed.  In 
whole-body sampling, the objective is to measure the amount of chemical that is deposited on the 
clothing or skin.  Workers are outfitted with overalls of certain material (e.g., cotton) before exposure; 
the overalls are analyzed using an appropriate method after exposure.  The removal technique 
involves washing (Brouwer et al. 2000), wiping (Wheeler and Stancliffe 1998), or tape stripping 
(Loffler et al. 2004; Reddy et al. 2002) where part of the stratum corneum is stripped off and depth 
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profiling is possible.  These techniques use solvents, gauze pads, or adhesive tapes to measure 
chemicals remaining on the skin after exposure.  The third technique uses a fluorescent compound to 
determine the area of exposure and to quantify the mass deposited onto the skin (Cherrie et al. 
2000); however, this technique is limited by cost and availability of equipment, and is not as widely 
used in the field as other techniques. 
 
1.2.3 Measurement of dermal exposure to JP-8 in the workplace 
    Occupational exposure to JP-8 can occur quite frequently because JP-8 is the most common 
source of chemical exposure for military personnel.  Exposures can occur during spills, transportation 
and storage of fuel, fueling, general maintenance and operation of aircrafts, cold engine starts, and 
performance testing (Subcommittee on Jet-Propulsion Fuel 8 2003).  Personnel exposed during these 
scenarios are ground crew, fuelers, maintenance workers, general troops, and cleanup crew.  Other 
scenarios where JP-8 exposure can occur are during the fueling of military tent heaters, and cleaning 
and degreasing with fuel.  Inhalation exposure is highly possible during hot temperatures (e.g., during 
the Persian Gulf War).  Inhalation exposures have been documented previously (Egeghy et al. 2003; 
Pleil et al. 2000).  The work by Egeghy et al. (2003) used benzene and naphthalene as markers for 
exposure to JP-8.  They found that dermal contact with JP-8 significantly contributed to the exposure 
of workers in the high-exposed group.   
 There is a paucity of field studies that have measured human dermal exposure to JP-8.  
Results of an acute dermal exposure study have been reported (Chao et al. 2005).  The dermal 
exposure measurements were conducted using a tape-strip technique (Chao and Nylander-French 
2004).  This technique measured the amount of JP-8 in the stratum corneum of the skin from 
successive tape strips of the skin of the fuel-cell maintenance personnel (Chao et al. 2005).  The 
mass of naphthalene did not change much between successive tape strips at the same site of 
exposure, suggesting that some components of JP-8 penetrated the skin.  The average whole-body 
dermal exposure to naphthalene was 5.84 ± 1.34 ln(ng·m-2) for the low-exposure group, 6.18 ± 1.35 
ln(ng·m-2) for the medium-exposure group, and 8.34 ± 2.23 ln(ng·m-2) for the high-exposure group.  
Further study of the determinants of dermal exposure discovered that skin irritation, use of booties, 
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working inside the fuel tank, and the duration of JP-8 exposure were significant factors that explained 
whole body dermal exposure to JP-8.  One of the limitations of this study was that only naphthalene 
was measured and not other components of JP-8.  Thus, only a snapshot of JP-8 was taken, and 
dermal exposure to other components of JP-8 remains unknown. 
 
1.3 Structure and Function of the Skin 
    While the assessment of dermal exposure involves measurement of the amount of chemical on the 
skin, it does not measure the amount of uptake into the body.  However, chemicals deposited onto 
the skin can be absorbed into the skin to cause local effects, pass through the skin to cause systemic 
effects, or evoke allergic reactions both locally and systemically.  As part of a dermal exposure 
assessment plan, it is important to understand the extent to which chemicals absorb into the skin and 
become systemically available.  This will aid in the control of harmful exposures.  The skin is 
composed of two layers: (1) the epidermis, which provides much of the barrier function, and (2) the 
dermis, which is a highly vascularized layer containing protein filaments, blood vessels, nerves, 
lymphatics, and epidermal appendages (Montagna and Parakkal 1974).  The epidermis has further 
been divided into the outer layer called the stratum corneum and the inner layer called the viable 
epidermis.  The sections below focus on the structure and function of the layers of the epidermis. 
 
1.3.1 Structure and function of the stratum corneum 
    Traditionally, the stratum corneum was considered to be an inert and homogenous tissue 
(Montagna and Parakkal 1974).  However, current research has shown that the stratum corneum is in 
fact structurally and biochemically complex (Harding 2004; Marks 2004).  The stratum corneum is an 
approximately 15 µm thick membrane comprised of ordered corneocytes each less than 1 µm in 
thickness.  The overall thickness of the stratum corneum depends on anatomical location, and can 
range from 5 µm in the scrotum to over 600 µm on the feet (Poet and McDougal 2002).  Corneocytes 
originate from the keratinocytes of the basal layer of the viable epidermis through a process of 
programmed cell differentiation called keratinization.  The corneocytes in the stratum corneum are 
connected by desmosomal proteins through lipids in the intercorneocyte space (Elias 1989; Kalinin et 
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al. 2001).  The main lipids are ceramides (50% by mass), fatty acids (10-20% by mass), and 
cholesterol (25% by mass) (Madison 2003).  The corneocytes embedded in the lipid lamellae make 
the stratum corneum hydrophobic.   
    The main function of the stratum corneum is to control the movement of materials in and out of the 
body.  Of primary importance is the movement of water.  Under normal circumstances, 0.5 L of water 
is lost through the stratum corneum each day; however, damage to the stratum corneum, as in 
psoriasis, can result in over 6 L lost per day (Marks 2004).  Another important function is to prevent 
xenobiotics from entering into the body.  The lipid lamellae, not the hair follicles and appendages of 
the stratum corneum, is believed to be the most important route of penetration for lipophilic chemicals 
(Marks 2004). 
 
1.3.2 Structure and function of the viable epidermis 
    The viable epidermis consists of living cells with a proliferating basal layer.  The four different cell 
types are keratinocytes, melanocytes, Langerhan’s cells, and Merkel cells (Montagna and Parakkal 
1974).  The keratinocytes are metabolically active cells, which accumulate keratin as they 
differentiate into corneocytes of the stratum corneum.  Melanocytes are cells that contain 
melanosomes, which produce melanin.  Langerhan’s cells are dendritic cells, which capture antigens 
and present them to lymphocytes for the initiation of an immune response (Elias 1989).  Merkel cells 
occur in the basal layer and are the terminal points to sensory nerve endings.  The overall thickness 
of the viable epidermis is from 50-100 µm depending on the location on the body.  The viable 
epidermis is a relatively hydrophilic skin layer.   
    The viable epidermis has many more functions than the stratum corneum.  One of these is 
protection from solar radiation.  Melanin granules are formed within the melanocytes and transferred 
to the keratinocytes for absorption of UV radiation.  The viable epidermis has an immunologic function 
via Langerhan’s cells.  The viable epidermis is also involved in transmission of sensory signals via 
Merkel cells.  Of notable mention is the presence of both phase I and phase II metabolism enzymes 
in the viable epidermis, such as families of cytochrome P450, esterases, and β-glucoronidase 
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(Mukhtar 1992).  The presence of these enzymes suggests that chemicals may be metabolized in the 
viable epidermis. 
 
1.3.3 Studies of percutaneous absorption 
    Chemical exposures on the skin set up a concentration gradient between the surface and the richly 
perfused dermis.  This gradient results in a transfer of mass that is dependent on the properties of the 
chemical and the layer(s) through which the chemical must traverse.  The mass transfer, or flux, of 
chemical across a thin homogeneous membrane has been described by Fick in his first law, which 
states that: 
 
     J = -D 
x
C
∂
∂       (1) 
 
where: 
  J is the flux of material across the membrane (mg/cm2·h) 
 D is the diffusion coefficient (cm2/h) 
 ∂C is the concentration gradient across the membrane (mg/cm3) 
 ∂x is the thickness of the membrane (cm) 
Assuming that there is no chemical in the dermis prior to exposure, the following expression for the 
permeability coefficient is defined (Moss et al. 2002): 
 
     Kp = C
J        (2) 
 
where: 
 Kp is the permeability coefficient (cm/h) 
 J is the steady-state flux (mg/cm2·h) 
 C is the concentration of chemical on the surface of the skin (mg/cm3) 
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Both in vitro and in vivo studies have been conducted to estimate Kp values for various compounds 
(Borras-Blasco et al. 2004; Pillai et al. 2004; Venier et al. 2004). 
    The study of percutaneous absorption of chemicals in vivo in humans is difficult and few methods 
exist.  One such method makes use of tracers (e.g., 14C) and tracks the amount of the tracer retained 
in the body (plasma) or excreted in feces and urine (West et al. 1987).  Another approach is to 
monitor the loss of material as it penetrates the skin (Wester and Maibach 1989).  It is assumed that 
the difference between the applied dose and the residual dose is the amount of chemical absorbed.  
One method that is gaining popularity involves tape stripping of the stratum corneum.  In this method, 
the chemical is applied to the stratum corneum for a short period of time, removed by successive tape 
applications, and urine/blood/feces are monitored to determine penetration across the skin (Rougier 
et al. 1987; Wester et al. 1998).  The tape-strip method has also been used with Fick’s law of 
diffusion to estimate permeability coefficients  (Pirot et al. 1997; Reddy et al. 2002).  This technique 
does not require sampling of biological media, such as urine and blood, but uses a quick and non-
invasive tape-strip method to measure amounts of a chemical in successive layers of the stratum 
corneum.  Hence both depth-profiling and time-course information is available to estimate dermal 
absorption parameters. 
    The ideal way to measure penetration of chemicals is by applying a chemical to human volunteers.  
Often, this is not feasible because many chemicals are too harmful to test in humans.  More often, 
skin penetration tests have been conducted in vivo in animals or in vitro using diffusion cell systems.  
Popular animal models are the mouse, rat, rabbit, pig, and monkey (Poet and McDougal 2002).  
Animal studies have shown that the pig is the best model as it most closely predicts penetration of 
chemicals across human skin (Poet and McDougal 2002).  More common is the use of diffusion cells 
with excised skin to study percutaneous absorption.  The basic design is a donor cell wherein which 
the chemical is applied, a receptor cell into which the chemical is received, and a flap of skin that 
separates the two cells.  The receptor solution (e.g., polyethylene glycol-20 oleyl ether and 
physiological saline) is sampled at various points in time and analyzed using analytical chemistry 
techniques, such as gas chromatography mass spectrometry (GC-MS) combined with head space 
solid phase microextraction (HS-SPME).  Fick’s law of diffusion is then used to mathematically 
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estimate the permeability coefficient.  The advantage of these in vitro experiments is that they can be 
used to estimate the amount of a chemical penetrating across animal skin.  However, their relevance 
to humans is inherently questionable because of the use of animal skin, skin viability, and perfusion of 
the skin in vitro.  Nevertheless, this design has been widely used for penetration studies of metals 
(Larese Filon et al. 2004), chemical warfare agents (Chilcott et al. 2001), and drugs (Wagner et al. 
2000). 
    The percutaneous absorption of JP-8 components has been characterized using diffusion cells 
(McDougal et al. 2000; Muhammad et al. 2004).  McDougal et al. (2000) used male rat skin with 
surface area of 4.9 cm2 to measure the permeability of JP-8 components.  They used a mixture of 
polyethylene glycol-20 oleyl ether (6% Volpo 20) and saline as their receptor solution.  The aromatic 
components of JP-8 had permeability coefficients that are significantly larger than the aliphatic 
components.  For example, naphthalene had a permeability coefficient of 5.1x10-4 cm/h whereas 
dodecane had a permeability coefficient of 1.4x10-5 cm/h.  Muhammed et al. (2004) also studied the 
permeation of JP-8 components using diffusion cells, but they improved on the work of McDougal et 
al. (2000) by using porcine skin.  They measured permeability coefficients of 2.1x10-4 cm/h for 
naphthalene and 2.5x10-6 cm/h for dodecane, both smaller than reported by McDougal et al. (2000) 
for rat skin.  In vivo studies of the percutaneous absorption of JP-8 components in humans have not 
been reported. 
 
1.4 Mathematical descriptions of percutaneous absorption 
    In order to make predictions of the quantity of chemical that penetrates the skin, and is available for 
systemic circulation, a mathematical description is needed.  This can be as simple as measuring the 
percent absorbed (Bronaugh and Franz 1986; Ross et al. 2004).  However, the main limitation of 
measuring percent absorbed is that it is appropriate only under tightly controlled experimental 
conditions.  In most situations, the process of absorption is non-linear with regard to length of 
exposure and concentration on the surface of the skin.  In this section, several mathematical 
descriptions for percutaneous absorption of chemicals are examined. 
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1.4.1 Quantitative Structure-Activity/Permeation Relationship models 
    Quantitative Structure Activity Relationship (QSAR) models attempt to relate the biological activity 
of a chemical to its physicochemical and structural properties using statistical methods (Basak et al. 
2003; Beliveau et al. 2003; Hawkins et al. 2004; Moss et al. 2002).   The variables used for prediction 
of percutaneous absorption should be relevant to the particular diffusion process.  Classical 
approaches have used three classes of descriptors: (1) hydrophobicity, (2) electronic properties, and 
(3) steric properties.  Based on permeability studies, a predictive equation has been built for 93 
compounds using the two descriptors: octanol-water partition coefficient (Kow) and molecular weight 
(MW) (Guy and Potts 1992).  The model has the following functional form: 
 
   log(Kp) = 0.71 × log(Kow) – 0.0061 × MW – 6.3    (3) 
 
The R2 was 0.67; however, Guy and Potts (1992) did not examine outliers and various Gauss-Markov 
assumptions, which state that (1) the expected value of the errors is zero, (2) all errors have the same 
variance, and (3) the errors are not correlated.  Since then, further developments have included 
hydrogen bonding (Lien and Gao 1995) and melting point (Barratt 1995).  The main weakness of 
QSAR models is that they treat the skin as one compartment, namely the stratum corneum, assuming 
that the viable epidermis presents relatively little barrier function to the percutaneous absorption of 
chemicals.   
 
1.4.2 Two-compartment skin models 
    The composition of the stratum corneum and viable epidermis, both which a chemical must 
penetrate to become systemically available, is very different.  The stratum corneum is comprised of 
dead cells and is very hydrophobic, whereas the viable epidermis is comprised of viable cells and is 
less hydrophobic.  Thus, the application of Fick’s law of diffusion may be inappropriate for chemicals 
that do not undergo diffusion via the lipid pathway but are transported through appendages (e.g., hair 
follicles) or undergo reactions with proteins.  Also, a simple diffusion model may not be realistic for 
compounds that are held in the stratum corneum or viable epidermis such that there is a lag-time 
 13
before the compounds enter the blood.  A more apt description of percutaneous absorption for such 
chemicals may be to treat the skin as two compartments with a different set of descriptors for each 
compartment. 
    Two-compartment models have been constructed in the past, and used to successfully predict 
exposures to chemicals (McCarley and Bunge 2001; Shatkin and Brown 1991).  Two-compartment 
models treat the stratum corneum and viable epidermis differently.  These models may also include a 
compartment representing the outer surface layer and a dermis layer that is highly vascularized and 
removes the chemical from the skin quite readily.  The rate constants for the two-compartment model 
constructed by Shatkin and Brown (1991) are functions of the partition coefficients, the thicknesses of 
the skin compartments, the fat content, molecular weight of the chemical, and diffusivity coefficients.  
The limitation of the two-compartment models is that there are more parameters needed in the 
mathematical description of percutaneous absorption, and these parameters may not always be 
available for the compound of interest. 
 
1.4.3 Physiologically based toxicokinetic models 
    The disposition of compounds that penetrate the skin and become available for systemic circulation 
can be described using physiologically based pharmacokinetic (PBTK) models.  In PBTK models, the 
body is compartmentalized into various tissue groups, enabling the calculation of the tissue dose of 
parent chemical and metabolites.  The parameters in a PBTK model are derived from relevant 
physicochemical, physiological, and biochemical properties of various tissues and the chemical of 
interest (Brown et al. 1997).  Each compartment is described by a mass balance differential equation 
(MBDE), and the set of equations is solved using numerical methods.  Further information about 
PBTK modeling, its history and application in chemical risk assessment can be found in recent 
reviews (Andersen 2003; Reddy et al. 2005). 
 
1.4.4 Mathematical descriptions of the percutaneous absorption of JP-8 
    PBTK models have been developed for some JP-8 components (Perleberg et al. 2004; Quick and 
Shuler 1999; Willems et al. 2001).  The decane model by Perleberg et al. (2004) was constructed for 
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inhalation exposure to decane in rats.  They found that the toxicokinetic behavior of decane could not 
be adequately explained by a flow-limited system.  Therefore, diffusion-limited equations were fit for 
brain, bone marrow, skin, fat, and spleen.  Further, a PBTK model for inhalation, ingestion, 
intravenous dosing, and intraperitoneal injection of naphthalene has been constructed (Quick and 
Shuler 1999).  This PBTK model consisted of 5 major tissue groups (lung, liver, fat, richly perfused 
tissue, poorly perfused tissue).  Willems et al. (2001) built upon this work by constructing a PBPK 
model for exposures to naphthalene in rats and mice.  All compartments except the blood 
compartment were treated as diffusion-limited.  They examined the inhalation and intravenous routes 
of exposure.  None of these models included the dermal route of exposure.  Therefore, extrapolations 
to occupational exposure conditions are limited to inhalation exposures only. 
 
1.5 Specific aims of this project 
    The primary objective of this project was to characterize the toxicokinetic behavior of aromatic and 
aliphatic hydrocarbons following dermal exposure to JP-8.  This objective was met by collecting 
dermal exposure data and constructing mathematical models of the skin.  A model was selected and 
expanded to include both the dermal and the inhalation routes of exposure.  A secondary objective of 
this investigation was to integrate complex chemical exposure and biomarker data into a PBTK model 
that could be used to improve assessment of human health risks.  The specific aims were: 
 
Specific Aim 1:  Examine the absorption and the penetration of JP-8 components across human skin 
in vivo, and contrast the results to rat or pig skin studies. 
Specific Aim 2:  Determine the structure of a mathematical model that optimally predicts the 
toxicokinetic behavior of aromatic and aliphatic hydrocarbons following dermal exposure to JP-8. 
Specific Aim 3:  Compare the contribution of dermal and inhalation exposures to the internal dose of 
naphthalene in the US Air Force personnel. 
 
 
 
 
 
 
CHAPTER 2 
 
DERMAL ABSORPTION AND PENETRATION OF JET FUEL COMPONENTS IN HUMANS 
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2.1 Abstract 
    Jet Propulsion Fuel 8 (JP-8) is the largest source of chemical exposures on military bases.  Dermal 
exposure to JP-8 has been investigated in vitro using rat or pig skin, but not in vivo in humans.  The 
purpose of this study was to investigate the absorption and penetration of aromatic and aliphatic 
components of JP-8 in humans.  A surface area of 20 cm2 was delineated on the forearms of human 
volunteers and 1 ml of JP-8 was applied to the skin.  Tape-strip samples were collected 30 min after 
application.  Blood samples were taken before exposure (t = 0 h), after exposure (t = 0.5 h), and 
every 0.5 hour for up to 4 hours past exposure.  The tape-strip samples showed evidence of uptake 
into the skin for all JP-8 components.  The blood data was used to estimate an apparent permeability 
coefficient (Kp).  The rank order of the apparent Kp was naphthalene > 1-methyl naphthalene = 2-
methyl naphthalene > decane > dodecane > undecane.  This rank order is similar to results from rat 
and pig skin studies.  However, this study demonstrates that rat and pig models of the skin over 
predict the internal dose of JP-8 components in humans.   
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2.2 Introduction 
    Jet Propulsion Fuel 8 (JP-8) is the standard fuel for military aircrafts and vehicles, and is the single 
largest source of chemical exposure found on military bases of the NATO nations (Zeiger and Smith 
1998).  Possible adverse health effects associated with JP-8 include neurological effects and cancers 
(Babu et al. 2004; Parent et al. 2000; Rhodes et al. 2003; Siemiatycki et al. 1987; Smith et al. 1997).  
The main route of exposure inferred in these studies is inhalation; however, JP-8, which replaced JP-
4, is less volatile and does not contain the lower molecular weight hydrocarbons found in gasoline.  
As a result, dermal exposure to JP-8 has been observed to affect the levels of urinary naphthalene 
metabolites, a biomarker of exposure to JP-8 (Chao et al. 2005; Chao et al. 2006).  However, it is not 
well understood how chemical components of JP-8 are absorbed into the skin and how they become 
systemically available.  Three types of study designs have been implemented to study dermal 
exposures to JP-8; these are field studies, in vitro experiments using excised skin, and in vivo studies 
using animal models. 
    Field studies of JP-8 use on military bases have identified sources of exposure as spills during 
transportation and storage of fuel, fueling, general maintenance and operation of aircrafts, cold 
engine starts, and performance testing (Subcommittee on Jet-Propulsion Fuel 8 2003).  Inhalation 
exposures are evident during these work processes (Egeghy et al. 2003; Pleil et al. 2000), but skin as 
a route of exposure is less well-characterized as only one field study has measured human dermal 
exposure to JP-8 (Chao et al. 2005; Chao et al. 2006). 
    In order to estimate the amount of JP-8 that penetrates the skin, measurements of both the applied 
dose and the internal dose are needed.  Diffusion cells and excised skin from animals have been 
used to estimate the extent of absorption and penetration of JP-8 components (Baynes et al. 2001; 
Kanikkannan et al. 2001a; Kanikkannan et al. 2001b; McDougal et al. 2000; Muhammad et al. 2004).  
McDougal et al. (2000) used male rat skin (surface area of 4.9 cm2) and a mixture of polyethylene 
glycol-20 oleyl ether (6% Volpo 20) and saline as the receptor solution to measure the permeability of 
JP-8 components.  They found that the aromatic components of JP-8 had permeability coefficients 
significantly larger than the aliphatic components.  These results were confirmed in a pig-skin study 
(Muhammad et al. 2004).   
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    Although in vitro studies are valuable for determining the permeation rates and the amount that is 
available for systemic circulation, they need validation under in vivo conditions to be usable in risk 
assessment.  However, few studies of in vivo exposures to JP-8 exist.  One of these exposed 
weanling pigs to 0.5 ml of JP-8 over an area of 3.14 cm2 for 0.5 h (Singh et al. 2003).  They found that 
more hexadecane (0.43 %) than xylene (0.17%) or heptane (0.14%) was absorbed into the skin after 
0.5 h exposure.  Blood measurements were not made, so permeability coefficients could not be 
calculated for comparison to in vitro experiments.  
    The primary objective of our study was to examine the absorption and penetration of JP-8 
components across human skin after the fuel was applied to the forearms of human volunteers.  
Building upon the results of previous studies (Chao and Nylander-French 2004; McDougal et al. 
2000; Muhammad et al. 2004; Singh et al. 2003), an appropriate blood sampling regimen was 
established for the current study to examine the amount of chemical that penetrates the skin and 
becomes systemically available.  The study design incorporated a validated tape-strip technique to 
quantify concentrations in the stratum corneum (Chao et al. 2005; Chao and Nylander-French 2004).  
The main hypothesis of the current study is that single-dose application data from controlled human 
exposures to jet fuel can be used to quantify the absorption and penetration of aromatic and aliphatic 
components of JP-8 for humans in vivo. 
 
2.3 Methods 
2.3.1 Study volunteers 
    Ten healthy adult volunteers (5 males and 5 non-pregnant females) with no occupational exposure 
to jet fuel were recruited for participation.  No restrictions on age, race, gender, or skin type were 
applied other than that the group was to be equally divided between males and females.  If volunteers 
had a history of cardiovascular disease or atopic dermatitis, were current smokers, or were on 
prescription medication for a current or chronic illness, they were excluded from the study.  
Volunteers were not permitted to drink any alcoholic beverages 24 hours before or during the 
experiment.  Individuals occupationally exposed to compounds chosen to represent JP-8 were also 
excluded (e.g., auto mechanics).  Approval for this study was obtained from the Office of Human 
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Research Ethics (School of Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, 
NC).  Informed consent was received from all study volunteers. 
 
2.3.2 General procedure 
    Upon arrival at the laboratory, the study volunteer was given a protective laboratory coat that was 
worn for the duration of the experiment.  A passive monitor was attached to the lapel of the volunteer 
to monitor levels of JP-8 in the personal breathing zone.  The volunteer’s forearms were examined for 
obvious skin defects (abrasions, inflammation) that could enhance or impair the penetration of JP-8.  
The exposure chamber shown in Figure 1 (20.3 cm width × 20.3 cm length × 18.8 cm height and total 
volume of 7706 cm3) was placed inside a fume hood to prevent possible inhalation of JP-8.  After the 
volunteer was seated comfortably, one forearm was placed palm up inside the exposure chamber, 
and two aluminum application wells (dimensions 2.5 cm × 4.0 cm = 10 cm2 per well) were pressed 
against the skin to prevent JP-8 from spreading during the experiment.  The exposure chamber was 
sealed for the duration of the experiment (0.5 h). 
    At the end of the 0.5 h exposure period, the two exposed skin sites were wiped with a gauze pad 
and tape-stripped as many as 10 times.  Tape strips were placed in 10 ml of acetone containing 1 
µg/ml of internal standards (naphthalene-d8).  All tape-strip samples were stored in 20 ml vials (I-
CHEM, Rockwood, TN) and refrigerated at 4°C.  Blood samples were drawn from the unexposed arm 
at baseline, 0.5 h, 1 h, 1.5 h, 2 h, 2.5 h, 3 h, and 3.5 h and collected in 6 ml test tubes containing 
sodium heparin (Vacutainer, Franklin Lakes, NJ).  The blood samples were transferred to 15 ml 
centrifuge tubes (Fisherbrand, Pittsburgh, PA) and stored at -80°C until analysis. 
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0.5 ml of JP-8 is 
applied to each 
of the two sites 
(total 1.0 ml) 
Two aluminum 
application wells of 
10 cm2 each.  Total 
surface area of 
exposure is 20 cm2.
 
 
Figure 1.   Schematic of the exposure chamber and aluminum application wells.  The exposure was 
done inside a fume hood to prevent inhalation exposure to JP-8 components. 
 
 
2.3.3 Dosing 
    The volume of JP-8 to be applied to the skin in order to have sufficient concentrations in blood was 
estimated using the limit of detection (LOD) of a published analytical method and estimates of 
permeability coefficients from an in vitro study (McDougal et al. 2000; Waidyanatha et al. 2003).  
Although the method by Waidyanatha et al. (2003) was developed for the analysis of naphthalene in 
urine, a similar LOD (5.0×10-4 ng/ml) was assumed to apply for blood samples.  Three times the LOD 
was assumed to be adequate for detection in blood.  A permeability coefficient of 5.1×10-4 cm/h was 
used to back extrapolate to surface levels of JP-8.  It was determined that 1 ml of JP-8 should 
produce measurable blood concentrations.  Neat JP-8 was applied to the volar forearm using a 0.5 ml 
gas-tight syringe through two openings on top of the exposure chamber; 0.5 ml was applied to each 
of two wells for a total of 1.0 ml JP-8 on an area of 20 cm2.  Upon application, the openings were 
sealed to prevent loss from the chamber. 
 
2.3.4 Tape-strip samples 
    Adhesive tape strips (Cover-RollTM tape; Beiersdorf, Germany) with dimensions 2.5 cm × 4.0 cm 
(10 cm2) were used to remove skin containing JP-8 from the stratum corneum.  The tape strips had 
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the same dimensions as the aluminum application wells.  Clean forceps were used to remove each 
tape strip without cross-contamination; the time it took to apply and remove 10 tape strips was 
recorded.  To minimize pressure-induced vasodilation, no direct pressure was applied to the exposed 
sites during the exposure, tape strip was applied to the skin by one finger stroke with sufficient 
minimal pressure to adhere the tape to the skin, and forceps were used to remove the tape.  This 
tape-strip method has been previously validated for multifunctional acrylates and jet fuel (Chao and 
Nylander-French 2004; Nylander-French 2000).  Tape-stripping has also been used in 
dermatopharmacokinetic studies of therapeutic agents (Loden et al. 2004; Shah 2001; Shah et al. 
1998). 
 
2.3.5 Chemicals 
    Six aromatic and aliphatic components of JP-8 were investigated in this study.  The aromatic 
components were naphthalene, 1-methyl naphthalene, and 2-methyl naphthalene, and the aliphatic 
components were decane, undecane, and dodecane.  These aromatic and aliphatic components 
were chosen because they represent the most abundant hydrocarbons in JP-8 by mass percentage 
(McDougal and Rogers 2004).  The reagents naphthalene, 1-methyl naphthalene, 2-methyl 
naphthalene, decane, undecane, and dodecane were purchased from Sigma-Aldrich (St. Louis, MO).  
Napthalene-d8 and dodecane-d26 (internal standards) were purchased from Cambridge Isotope 
Laboratories (Andover, MA).  Acetone and methanol (HPLC grade) were purchased from Sigma-
Aldrich (St. Louis, MO).  JP-8 was collected for U.S. EPA directly from bulk storage at Warner Robins 
Air Force Base, Georgia.  Chemical characterization of this fuel was determined by dissolving 1 µl of 
fuel in 10 ml of acetone with internal standard.  The physico-chemical properties of the three aromatic 
and three aliphatic compounds analyzed in this study are shown in Table 1. 
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Table 1. Physico-chemical properties of naphthalene, 1-methyl naphthalene, 2-methyl 
naphthalene, decane, undecane, and dodecane.  Permeability coefficients (Kp) are taken 
from McDougal et al. (2000). 
 
Property Naphthalene 1-methyl 
Naphthalene
2-methyl 
Naphthalene
Decane Undecane Dodecane 
 
 
 
 
 
 
 
 
CH3
 
 
 
 
 
 
 
Chemical 
formula 
C10H8 C11H10 C11H10 C10H22 C11H24 C12H26 
MW (g/mol) 128.3 142.2 142.2 142.3 156.3 170.3 
Concentration 
in JP-8 
(mg/ml) 
3.0 2.5 2.1 28.3 111.2 102.9 
Kp (cm/h) 5.1x10
-4
 1.6x10
-4
 1.6x10
-4
 5.5x10
-5
 2.5x10
-5
 1.4x10
-5
 
 
 
 
2.3.6 Chemical analysis 
    Personal breathing-zone (PBZ) samples were thermally desorbed with a Perkin Elmer automatic 
thermal desorption (ATD) 400 system (Perkin Elmer, Norwalk, CT) for 2 min at 225°C onto a cold 
trap.  The cold trap was subsequently heated to 225°C and transferred to a transfer line at 200°C.  
The samples were analyzed with a Hewlett Packard 6890 Series II gas chromatograph (GC) 
equipped with a DB-1 column (60 m × 0.53 mm × 1.5 µm; J&W Scientific, Folsom, CA) and a 
photoionization detector (PID; HNU Systems, Inc., Newton, MA).  The GC oven conditions were as 
follows: 40°C for 5 min, 10°C/min to 75°C, 5.5°C/min to 175°C, and 50°C/min to 260°C for 6 min. 
    Tape-strip samples were analyzed by gas chromatography mass spectrometry (GC-MS).  A 
Thermoquest Trace GC (Thermo Electron Corporation, Austin, TX) coupled with a Combi Pal 
autosampler (CTC Analytics, Zwingen, Switzerland) and a Finnigan Polaris Q quadrupole ion trap MS 
(Thermo Electron Corporation, Austin, TX) in electron ionization mode, was used for the chemical 
analysis.  Separation of the sample was done with a fused-silica capillary column coated with a 
mixture of 5% diphenyl/95% dimethyl polysiloxane (30 m × 0.25 mm × 0.25 µm; RTX-5MS, Restek 
CH3
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Corporation, Bellefonte, PA).  The oven temperature was 40°C (3 min) and then 10°C/min to 290°C 
(10 min).  About 1 µl of sample was directly injected into the inlet.  The injector and auxiliary 
temperatures were kept at 280°C and 300°C, respectively.  Samples were injected in the splitless 
mode; the split valve was kept closed for 2 min.  Helium was used as the carrier gas (1.0 ml/min) with 
vacuum compensation enabled.  The MS conditions were as follows: source temperature 200°C; full-
scan mode (60-160 amu) with electron impact ionization (70 eV).  The ions used for quantitation were 
m/z 128 (naphthalene), 142 (1-methyl and 2-methyl naphthalene), 136 (naphthalene-d8), 71 (n-
decane, n-undecane, n-dodecane), and 98 (dodecane-d26).  The number of microscans was set at 2 
and the max ion time at 200 ms.  Samples were quantified using an 11-point calibration curve with 
concentrations ranging from 0 to 11 µg/ml.  A typical chromatogram for a tape-strip sample is shown 
in Figure 2. 
    Blood samples were analyzed using head-space solid-phase microextraction (HS-SPME) and the 
GC-MS system described above.  Modifications were made from published methods (Cardinali et al. 
2000; Waidyanatha et al. 2003).  Briefly, whole blood (1 ml) was added to a 10 ml headspace vial 
with crimp top (Microliter, Suwanee, GA) containing 3 ml of deionized water, 2 g of NaCl, and 2 µl of 5 
ng/ml internal standard.  The vial was put into an aluminum block (CTC Analytics, Zwingen, 
Switzerland) for heating and agitating at 45ºC and 250 rpm (1 min).  A 100 µm polydimethyl-siloxame 
(PDMS) fiber (Supelco, Bellefonte, PA) was inserted into the head-space of the vial for 20 min.  The 
needle containing the SPME fiber was withdrawn and introduced into the inlet of the GC for 20 min.  
The inlet temperature was set at 230°C; an IceBlue septum (Restek, Bellefonte, PA) and a liner with 
an internal diameter of 0.8 mm (SGE, Austin, TX) were used.  All other GC-MS conditions were the 
same as for the analysis of tape-strip samples.  Quantification was carried out using an 8-point 
calibration curve ranging from 0 to 3 ng/ml.  A typical chromatogram for a blood sample is shown in 
Figure 3.  Much cleaner chromatograms were obtained from blood samples relative to tape-strip 
samples because of the use of the SPME device. 
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Figure 2. MS chromatogram (total ion count) from the first tape-strip sample collected from one 
study volunteer.   
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Figure 3. MS chromatogram (total ion count) from one blood sample.  This blood sample was 
collected 1 hour after the end of exposure.  The cleaner spectrum compared to the tape-
strip sample in Figure 2 is due to the use of the HS-SPME device. 
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2.3.7 Data analysis 
    Exploratory analyses of skin and blood concentrations of JP-8 components were conducted using 
descriptive statistics.   The skin and blood concentrations were plotted as functions of time.  The first 
tape strip was not included in these plots because of potential residual contamination from the dose 
applied to the skin (Pershing et al. 2002; Pershing et al. 2003; Shah 2001; Shah et al. 1998).  The 
volume of blood was estimated using allometric relationships (Davies and Morris 1993).  The 
equation is Volume of blood (Vb) = 72.447 × (body weight in kg)1.007.  Vb was used to estimate the 
total mass of naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, decane, undecane, and 
dodecane in the blood of each volunteer.  The steady state flux (J, µg/cm2 per h) was estimated from 
the slope of the linear portion of the cumulative mass per cm2 vs. time curve.  The slope of the curve 
during the uptake period (i.e., exposure duration) was estimated for each subject.  The permeability 
coefficient (Kp, cm/h) was estimated by dividing the flux by the concentration of the chemical (CJP-8, 
µg/cm3) in the 1 ml of JP-8 that was applied to the skin (McDougal and Boeniger 2002): 
 
8JP
p C
JK
−
=       (4) 
 
    Our study design for humans is similar to in vitro studies that have used static diffusion cells.  A 
chamber (i.e., donor cell) was used that sealed the exposure region.  Blood samples were collected 
from the opposite arm to the one used for exposure (i.e., receptor cell).  The main differences 
between our study and static diffusion-cell experiments were: (1) the duration of exposure was limited 
to 0.5 h, (2) real human skin was used, thus introducing variability in structure and content of the 
different layers of skin, (3) the volume of the blood could not be controlled but was inferred by 
allometric relationships, and (4) compounds underwent elimination from the central compartment (i.e., 
receptor cell).  These differences will affect the estimates of Kp made in vivo.  To distinguish Kp 
estimated in our study from Kp estimated in vitro, we will call it the “apparent Kp” from here on. 
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2.4 Results 
2.4.1 Study volunteers 
    The average age of the volunteers was 27, which ranged from 21 to 37 years old.  Seven of the 
study volunteers were Caucasians, one Asian, one African American, and one was mixed Asian-
Caucasian.  The mean body mass index (BMI) was 21 kg/m2 and ranged from 19-25 kg/m2.  Further 
information about the study volunteers is reported in Table 2.  All PBZ samples were below the limit of 
quantitation reported by Egeghy et al. (2003).    
 
 
Table 2. Demographics of the study population. 
 
Volunteer Age Gender Ethnicity Height 
(ft, in) 
Weight 
(lbs) 
*Volume 
of blood 
(L) 
Main mode of 
transportation 
Creams/lotions 
used 
1 23 M Caucasian 6' 0" 185 6271 bus and car none 
2 34 M Asian 5’7” 123 4157 car none 
3 22 F Black 5' 4" 116 3919 bus lotion 
4 24 F Caucasian 5' 3" 125 4225 bus none 
5 28 M Caucasian 6' 2" 160 5418 car none 
6 24 M Caucasian 6' 3" 185 6271 car none 
7 37 M Caucasian 5' 10" 140 4736 car/motorcycle none 
8 32 F Caucasian 5' 8" 130 4396 car Keri skin 
9 24 F Caucasian 5' 5" 120 4055 bus/car Jason organic 
honey 
10 21 F Asian-
American 
5' 9" 155 5247 walk/car Bath & Body 
works 
 
*Volume of blood = 72.447 x (body weight in kg)1.007 (Davies and Morris, 2003) 
 
 
2.4.2 JP-8 characterization 
    The composition of JP-8 varies from batch to batch (McDougal et al. 2000).  The weight percent of 
the aromatic and aliphatic hydrocarbons in the sample of JP-8 used in this study were 0.3% 
naphthalene (3.0 mg/ml), 0.3% 1-methyl naphthalene (2.5 mg/ml), 0.2% 2-methyl naphthalene (2.1 
mg/ml), 3.3% decane (28.3 mg/ml), 12.8% undecane (111.2 mg/ml), and 11.8% dodecane (102.9 
mg/ml).  Compared to the sample analyzed by McDougal et al. (2000), this batch contained a higher 
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fraction of undecane (111.2 mg/ml vs. 48.4 mg/ml) and dodecane (102.9 mg/ml vs. 36.1 mg/ml), and 
a lower fraction of 1-methyl and 2-methyl naphthalene (4.6 mg/ml vs. 9.9 mg/ml). 
 
2.4.3 Skin absorption 
    After the 0.5 h exposure to JP-8, the remaining jet fuel was wiped off the surface of the skin and 
successive tape strips were used to sample different depths of the stratum corneum.  The mass per 
cm2 of naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, decane, undecane, and dodecane 
in each of the tape strips are reported in Table 3.  The mass from each of the two exposure sites 
were combined to estimate the average total mass per cm2 of exposure for each component of JP-8.  
The results show that JP-8 was absorbed into the skin during the 0.5 h exposure period as all 
compounds were quantifiable in the tape-strip samples.  As expected, the mass per cm2 for each 
chemical decreased rapidly with successive tape strips.  The highest mass per cm2 was found in the 
first tape strip.  The rapid reduction in mass with depth is shown graphically in Figure 4.  The aromatic 
compounds were quantifiable in all tape-strip samples.  Similarly, undecane and dodecane were 
quantified in all tape-strip samples.  Decane showed a very different pattern.  Decane was not 
quantifiable after the 4th tape strip.  Therefore, the plot in Figure 4 quickly reached an asymptotic 
value. 
 
 
AROMATIC
0.0
0.7
1.4
1 2 3 4 5 6 7 8 9 10
Tape Strip #
Pe
rc
en
t o
f A
pp
lie
d 
D
os
e 
(%
)
naphthalene 1-methyl naphthalene 2-methyl naphthalene
ALIPHATIC
0.0
0.4
0.8
1 2 3 4 5 6 7 8 9 10
Tape Strip #
Pe
rc
en
t o
f A
pp
lie
d 
D
os
e 
(%
)
decane undecane dodecane
Pe
rc
en
t o
f A
pp
lie
d 
D
os
e 
(%
)
Pe
rc
en
t o
f A
pp
lie
d 
D
os
e 
(%
)
 
 
Figure 4. Percent of applied dose (mean) plots for aromatic and aliphatic hydrocarbons by tape-
strip number.  The first tape strip was not included in these plots because of potential 
residual contamination from the dose applied to the skin.   
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Table 3. Mass per area (µg/cm2) of aromatic and aliphatic hydrocarbons in tape strips. 
 
3.720.53.515.1-ND10
5.526.74.418.1-ND9
8.333.26.724.8-ND8
9.640.89.329.8-ND7
16.454.211.539.5-ND6
26.667.417.147.3-ND5
54.2110.526.971.14.61.44
192.2249.543.3115.96.77.33
587.0678.7237.4291.029.929.72
1971.27277.02233.74032.7213.2237.01
SDMeanSDMeanSDMeanTape 
Strip
DodecaneUndecaneDecane
0.30.50.40.53.21.810
0.50.70.60.63.32.09
0.60.90.60.90.71.38
0.71.20.81.13.42.57
0.81.70.81.73.43.06
1.12.11.12.21.02.65
2.44.02.64.05.05.34
7.08.76.78.93.77.63
19.625.420.826.310.317.12
91.4283.3101.6304.4126.5216.11
SDMeanSDMeanSDMeanTape 
Strip
2-Methyl Naphthalene1-Methyl 
Naphthalene
Naphthalene
 
 
SD = Standard Deviation 
ND = None Detected 
 
 
2.4.4 Skin penetration 
    Figure 5 shows the cumulative mass of compound in blood per cm2 of exposed area vs. time plot 
for one volunteer.  We observed that the flux of the aliphatic components was greater than the flux of 
the aromatics because the concentration of the aliphatics in JP-8 was more than an order of 
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magnitude greater than the concentration of the aromatics.  The slopes of the curve for aromatic 
compounds began to decrease at 120 min but did not reach zero.  For undecane and dodecane, the 
cumulative blood mass per cm2 continued to increase throughout the 4 h observation period.  Across 
compounds, the linear portion of the graph occurred between 0 and 60 min with no evidence of a lag-
time; therefore, these time points were used for estimating the apparent Kp.  Individual estimates of 
the apparent Kp from all volunteers are summarized in Table 4.  The apparent Kp was calculated for 
each volunteer and component of JP-8, assuming the absorbed compounds were restricted to the 
blood compartment in the body.  The mean apparent Kp in decreasing order is naphthalene > 1-
methyl naphthalene = 2-methyl naphthalene > decane > dodecane > undecane.  A Student’s t-test for 
comparison of the apparent Kp estimates for 1-methyl naphthalene and 2-methyl naphthalene showed 
no statistically significant difference (p > 0.05). 
 
 
Table 4. Apparent permeability coefficients (cm/h) of aromatic and aliphatic hydrocarbons for each 
study volunteer. 
 
Volunteer Naphthalene 1-methyl 
Naphthalene
2-methyl 
Naphthalene
Decane Undecane Dodecane 
1 1.6E-04 1.3E-05 5.3E-05 8.5E-06 2.1E-07 1.3E-06 
2 3.4E-05 2.8E-05 3.1E-05 8.6E-06 3.6E-07 1.5E-06 
3 3.2E-05 3.1E-05 3.0E-05 7.6E-06 2.3E-07 3.0E-06 
4 3.7E-05 2.7E-05 3.2E-05 1.2E-05 2.5E-07 2.0E-06 
5 5.4E-05 2.8E-05 2.9E-05 3.3E-06 6.7E-07 1.3E-06 
6 5.7E-05 3.3E-05 3.0E-05 8.0E-06 4.8E-07 1.5E-06 
7 4.1E-05 3.1E-05 3.0E-05 7.1E-06 3.3E-07 1.5E-06 
8 4.1E-05 2.9E-05 3.1E-05 5.6E-06 4.1E-07 1.3E-06 
9 3.3E-05 3.1E-05 3.0E-05 2.2E-06 7.6E-07 1.1E-06 
10 4.2E-05 3.5E-05 2.8E-05 2.0E-06 8.3E-07 1.2E-06 
mean 5.3E-05 2.9E-05 3.2E-05 6.5E-06 4.5E-07 1.6E-06 
SD 3.8E-05 5.9E-06 7.4E-06 3.3E-06 2.3E-07 5.6E-07 
minimum 3.2E-05 1.3E-05 2.8E-05 2.0E-06 2.1E-07 1.1E-06 
maximum 1.6E-04 3.5E-05 5.3E-05 1.2E-05 8.3E-07 3.0E-06 
 
 
SD = Standard Deviation 
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Figure 5. The time courses of the cumulative mass of aromatic and aliphatic hydrocarbons in blood 
per cm2 of exposed skin area for one study volunteer.  The slope (i.e., flux) was divided 
by the concentration of the specific chemical in JP-8 to estimate the apparent 
permeability coefficient.  The apparent permeability coefficient was estimated using the 
first three data points for each chemical. 
 
 
2.5 Discussion 
    Chemicals placed on the skin undergo absorption into the stratum corneum and evaporation from 
the surface of the skin.  After absorption, the chemicals may be stored in deeper layers of the stratum 
corneum or in the viable epidermis, or they may penetrate into the dermis for eventual movement into 
the systemic circulation.  Some absorbed compound may also transfer back to the skin surface and 
evaporate into the surrounding air.  While instruments and techniques (e.g., washing, wiping, tape-
stripping, biological monitoring) exist for measuring dermal exposures, the amount of uptake into the 
human body and the dose available for systemic circulation are not well understood and are often 
inferred from in vitro and in vivo studies using animal models.  The current study was conducted to 
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determine whether the process of absorption and penetration across the human skin can be 
described in humans using a non-invasive tape-strip method combined with trace analytical 
techniques.   
    The skin is composed of two main layers: (1) the epidermis, which provides much of the barrier 
function and (2) the dermis, which is a highly vascularized layer containing fibrous proteins, blood 
vessels, nerves, lymphatics, and epidermal appendages (Montagna and Parakkal 1974).  The 
epidermis consists of the hydrophobic layer called the stratum corneum and the hydrophilic layer 
called the viable epidermis.  Measurement of the amount of chemical on (or in, which is intended 
here) the surface layer of the skin will give an indication of how rapidly the mass of chemical is 
reduced from this layer.  Successive tape-strip samples give an indication of the depth of absorption 
as well as some indication of the rate of absorption (Loffler et al. 2004; Reddy et al. 2002; Surber et 
al. 1999).  In our study, tape-stripping was conducted to better understand the absorption of JP-8 
components into the skin.  Our results suggest that there is absorption of both aromatic and aliphatic 
components of JP-8, as components were detected as deep as the 10th tape-strip sample.   
    It is well known that the mass of stratum corneum removed decreases with successive tape-strip 
samples collected at the same site (Jacobi et al. 2005).  Hence in our study, the decreasing mass of 
the chemical measured per tape strip may be the result of the decreasing mass of stratum corneum 
removed with increasing number of tape strips.  In this study, we found that the mass of the chemical 
on the last tape strip was less than 1% of the mass measured on the first tape strip, suggesting that 
there is little mass of the chemical left in deeper layers of the stratum corneum.  The mass of stratum 
corneum harvested using tape strips does not decrease as appreciably (Jacobi et al. 2005).  
Therefore, we conclude that, because we detected very little chemical in the deeper layers of the 
stratum corneum, the residence time in the stratum corneum was not very long. 
    McDougal et al. (2000) also quantified the amount of JP-8 components remaining in the skin after 
the diffusion-cell experiment was completed.  They were able to measure only 6 components 
(nonane, decane, undecane, dodecane, tridecane, and tetradecane).  These compounds are aliphatic 
with high octanol:water partition coefficients.  In a separate experiment, they measured the presence 
of dibromomethane (a volatile compound) and found that evaporative loss from skin was negligible 
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based on a mass balance study.  They suggested that evaporative losses could not be the reason for 
not being able to detect the aromatic components in the skin.  It is possible that the straight chain 
compounds may be stored in deep layers of the skin prior to becoming available for systemic 
circulation.  This is consistent with the results from our study.  We noticed that, for some volunteers, 
the blood concentration for aliphatic compounds continued to increase after the 2nd blood sample was 
collected; this was not observed for aromatic compounds.  Further, decane could not be quantified 
beyond the 4th tape strip, suggesting a short residence time in the stratum corneum.  These results 
suggest that aliphatic compounds may be stored in deeper skin layers. 
    Our results were comparable to results from in vitro studies that measured the permeability 
coefficients of aromatic and aliphatic components of JP-8.  Aromatic compounds were estimated to 
have apparent Kp values an order of magnitude larger than aliphatic compounds.  Further, 
naphthalene was estimated to have the largest apparent Kp.  The relative order of apparent Kp values 
in terms of magnitude were similar to the results reported by McDougal et al. (2000).  The only 
exception was undecane, which had the smallest apparent Kp.  Our results are also similar to 
Muhammad et al. (2004) who reported Kp estimates for naphthalene and dodecane of 2.1×10-4 cm/h 
and 2.5×10-6 cm/h, respectively.  These estimates may be more comparable to our study because 
they used pig skin, which is a more widely accepted model for human skin.   
    Our apparent Kp values are smaller by an order of magnitude than Kp values estimated using 
diffusion cells.  The most likely reason for this difference is our assumption that all absorbed fuel 
components are retained in the blood compartment.  More accurate estimates will be possible using a 
pharmacokinetic model that describes the absorption, distribution and elimination of these 
components in the body.  Nonetheless, some differences might be expected between human and 
other species.  Rat skin has been suggested to be more permeable than human skin (McDougal et al. 
2000).  Pig skin, although a well-accepted model for studying human dermal absorption and 
penetration (Wester et al. 1998), overestimates the permeation of compounds across human skin.  
This was demonstrated in a study of caffeine and testosterone across human epidermal sheets, pig 
skin, and the reconstructed skin EpiDerm™ and SkinEthic® (Schreiber et al. 2005).  In addition, 
although pig skin is a better model of human skin than rat skin, its physiology is equivalent to that of a 
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young child (Bronaugh and Maibach 1999).  Reconstituted skin models, although an appealing 
alternative, are not regarded as useful for in vitro penetration studies mainly due to weak barrier 
properties when compared to fresh human skin, and equivalent or inferior to mouse, rat, and pig skin 
(Schmook et al. 2001).  While a smaller value of Kp in humans versus these other model systems is 
not unexpected, the 10-fold difference is certainly an overestimate of the species differences in this 
parameter. 
    Principles from Fick’s Law of Diffusion can be used to estimate the total amount of chemical that 
might penetrate across a permeable membrane.  Fick’s Law of Diffusion states that the flux across a 
membrane is proportional to the concentration gradient across that membrane.  From this Law, one 
can derive the following expression to estimate the internal dose (M) of a chemical (McDougal and 
Boeniger 2002): 
 
M = Kp × CJP-8 × A × t     (5) 
 
where A is the area of exposure and t is the duration of exposure.  The amount of chemical that might 
penetrate the skin for an exposure scenario of 1 h on both hands (840 cm2) can be estimated with this 
equation.  To illustrate, we use Kp values determined from rat skin, pig skin, and our study to estimate 
the internal dose of naphthalene: Mrat = 1.29 mg, Mpig = 0.53 mg, and Mhuman = 0.13 mg.  The Kp from 
rat skin overestimates human internal dose by a factor of 10, and the Kp from pig skin by a factor of 4.  
An individual who is exposed on the hands only must be exposed to JP-8 for 10 hours in order to 
have the same internal dose estimated using the rat Kp. 
    In summary, our study demonstrates that it is possible to quantify the absorption and penetration of 
individual components of JP-8 across human skin in vivo.  Our results are similar to in vitro studies 
that use diffusion cells and pig skin.  Our tape-strip data showed evidence of absorption of 
naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, decane, undecane, and dodecane, 
although decane seemed to disappear faster from the surface of the stratum corneum.  We estimated 
that aromatic components of JP-8 penetrate faster than the aliphatic components.  We showed that 
the flux of the aliphatic components is greater than the flux of the aromatic components because the 
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concentration of the aliphatics in JP-8 is more than an order of magnitude greater than the 
concentration of the aromatics.  Our overall estimates of the apparent Kp were smaller than the in 
vitro estimates.  Consequently, our study shows that permeability coefficients estimated in vitro may 
overestimate the internal dose of various components of JP-8.  The results of our study need to be 
interpreted with caution because in vitro systems do not account for clearance mechanisms, i.e., 
processes such as uptake into peripheral tissues, binding to proteins, metabolism, and exhalation are 
not incorporated in diffusion-cell experiments.  Future work will incorporate these clearance 
mechanisms into a mathematical model of the skin to quantify the rates of absorption, distribution, 
and elimination of JP-8 components from exposures on the human skin. 
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3.1 Abstract 
    Workers, both in the military and the commercial airline industry, are exposed to jet fuel by 
inhalation and dermal contact.  We present a dermatotoxicokinetic (DTK) model that quantifies the 
absorption, distribution, and elimination of aromatic and aliphatic components of jet fuel following 
dermal exposures in humans.  Kinetic data were obtained from 10 healthy volunteers following a 
single dose of JP-8 to the forearm over a surface area of 20 cm2.  Blood samples were taken before 
exposure (t = 0 h), after exposure (t = 0.5 h), and every 0.5 h for up to 4 h past exposure.  The DTK 
model that best fit the data included 5 compartments.  The skin was described as two compartments: 
(1) the stratum corneum and (2) the viable epidermis.  Addition of a storage compartment improved 
the model fit of the data.  The DTK model was used to predict blood concentrations of the 
components of JP-8 based on dermal exposure measurements made in occupational exposure 
settings in order to better understand the toxicokinetic behavior of these compounds.  Monte Carlo 
simulations of dermal exposure and cumulative internal dose demonstrated no overlap among the 
low-, medium-, and high-exposure groups.  The DTK model provides a quantitative understanding of 
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the relationship between the mass of JP-8 components in the stratum corneum and the 
concentrations of each component in the systemic circulation.  The model may be used for the 
development of a toxicokinetic modeling strategy for multi-route exposure to jet fuel.   
 
3.2 Introduction 
    Occupational and environmental exposure assessments aim to quantify the uptake of toxicants 
through inhalation, ingestion, and dermal contact with environmental media (e.g., air, soil, water).  
Historically, inhalation exposures have been the focus of occupational and environmental exposure 
assessments.  For the most part, the dermal route has been neglected, making it difficult to assess its 
importance relative to other routes of exposure.  However, recent interest in dermal exposure 
assessment has been spawned by the decreasing trend in inhalation exposures to chemicals in the 
workplace (Sartorelli 2002; Schneider et al. 2000; Semple 2004; Semple 2005). 
    Current dermal exposure assessment strategies make use of  three types of sampling techniques 
based on surrogate skin, removal, or a fluorescent tracer (Fenske 1993; Nylander-French 2003).  
One of the more promising methods is tape stripping (a removal technique), which is a method of 
direct sampling of the amount of chemical in the stratum corneum (Chao et al. 2005; Chao et al. 
2006; Chao and Nylander-French 2004; Fent et al. in press; Jacobi et al. 2005; Nylander-French 
2000; Surber et al. 1999).  In tape stripping, part of the stratum corneum is removed and the rate and 
extent of dermal absorption is quantified.  Tape stripping has been used in bioequivalence studies of 
therapeutic agents (Loden et al. 2004; Pershing et al. 2002; Pershing et al. 2003; Shah 2001) and for 
measurement of dermal exposures to jet fuel in occupational exposure settings (Chao et al. 2005; 
Chao et al. 2006).   
    The tape-strip sampling technique has not been fully utilized partly due to inconsistent 
standardization.  For example, normalization of the mass measured on tape strips is done by dividing 
the mass of chemicals on tape strips by the mass of stratum corneum removed (Reddy et al. 2002) or 
by the keratin content (Chao and Nylander-French 2004).  A standard approach for reporting tape-
strip data has not yet been determined.  In addition, there is insufficient evidence that tape-strip 
measurements from different exposure groups (i.e., high-, medium-, or low-exposure) are 
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representative of exposure based on internal dose metrics (e.g., blood and urine biological markers of 
exposure).  A paucity of studies have demonstrated an association between dermal exposures 
measured using the tape-strip technique and urinary metabolite levels in humans under occupational 
exposure conditions (Chao et al. 2006).  Clearly, demonstrating that tape-strip measurements are 
predictive of internal dose can be of benefit to exposure assessment and epidemiological studies. 
    Quantification of the absorption, distribution, metabolism, and elimination of chemicals that may 
come into contact with the skin is necessary for assessing exposures and human health risks 
associated with occupational and environmental exposures to chemicals.  Membrane models have 
been used to quantify the toxicokinetic behavior of chemicals in the skin (Pirot et al. 1997; Reddy et 
al. 2002).  In membrane models, skin is defined as a homogeneous membrane and the diffusion 
across the membrane is described by Fick’s first law of diffusion: 
 
J = -D 
x
C
∂
∂       (6) 
 
where J is the flux of material across the membrane (mg/cm2/hr), D is the diffusion coefficient (cm2/h), 
∂C is the concentration gradient across the membrane (mg/cm3), and ∂x is the thickness of the 
membrane (cm).  The main limitation to applying membrane models to tape-strip sampled data is that 
the mathematical treatment is difficult and cumbersome.  Alternatively, compartmental models have 
been developed to quantitatively describe the dermal absorption and penetration of chemicals (Guy et 
al. 1985; Qiao et al. 2000; Shatkin and Brown 1991; Williams and Riviere 1995).  However, a 
compartmental model of the skin that relates tape-strip measurements to internal dose has not been 
reported.  Though compartmental models are not strictly representative of a complex tissue like the 
skin, they are easier to implement and can be combined with systemic compartmental models for 
quantitation of the toxicokinetic behavior of chemicals following dermal exposures.   
    In this study, we evaluated four different compartmental models of dermal exposure to jet-
propulsion fuel 8 (JP-8).  JP-8 is a fuel used extensively in military vehicles by member states of 
NATO (Subcommittee on Jet-Propulsion Fuel 8 2003).  Dermal exposure to JP-8, which occurs 
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occupationally, may contribute to systemic levels of various aromatic and aliphatic hydrocarbon 
components (Chao et al. 2006; Serdar et al. 2004).  We report in this paper data-based 
compartmental models (Andersen 1991).  Data-based compartmental models of the skin have been 
referred to as dermatotoxicokinetic (DTK) models (Qiao et al. 2000); for consistency, we will also use 
this terminology.  The main objective of our study was to construct a DTK model of the skin that 
quantitatively characterized and predicted the toxicokinetic behavior of JP-8 following controlled 
dermal exposures.  A second objective was to examine the effect of dermal exposure variability on 
blood concentrations of JP-8 components.  The following chemical components of JP-8 were 
examined: naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, decane, undecane, and 
dodecane.  Data derived from tape-strip and blood samples that were collected from dermal only 
exposed human volunteers provided the basis for model development.  The results of our study are 
intended to facilitate the development of a modeling strategy for multi-route exposures to jet fuel. 
 
3.3 Methods 
3.3.1 Study population 
    Ten volunteers (five female and five male) were recruited for this study.  The average age of the 
volunteers was 27 and ranged from 21 to 37 years.  Seven of the study volunteers were Caucasian.  
One volunteer was Asian, another African American, and one was mixed Asian-Caucasian.  The 
mean body mass index (BMI) was 21 kg/m2 and ranged from 19-25 kg/m2.  Approval for this study 
was obtained from the Institutional Review Board on Research Involving Human Subjects (School of 
Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC). 
 
3.3.2 Experimental design 
    Exposures were conducted inside a chamber with dimensions of 20.3 cm width × 20.3 cm length × 
18.8 cm height and a total volume of 7706 cm3 (Chao and Nylander-French 2004).  The volunteer’s 
forearm was placed palm up inside the exposure chamber, and two aluminum application wells 
(dimensions 2.5 cm × 4.0 cm = 10 cm2 per well) were pressed against the skin to prevent JP-8 from 
spreading during the experiment.  A total of 1 ml of neat JP-8 was applied to the skin.  The exposure 
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chamber was sealed for the duration of the 0.5 h experiment.  At the end of the 0.5 h exposure 
period, the exposure sites were wiped with gauze pads and tape stripped up to 10 times.  Tape strips 
were placed in 10 ml of acetone containing 1 µg/ml of internal standards (naphthalene-d8 and 
dodecane-d26).  All tape-strip samples were stored in 20 ml vials (I-CHEM, Rockwood, TN) and 
refrigerated at 4°C.  Blood samples were drawn from the unexposed arm at baseline, 0.5 h, 1 h, 1.5 
h, 2 h, 2.5 h, 3 h, and 3.5 h and collected in 6 ml test tubes containing sodium heparin (Vacutainer, 
Franklin Lakes, NJ).  The blood samples were transferred to 15 ml centrifuge tubes (Fisherbrand, 
Pittsburgh, PA) and stored at -80°C. 
 
3.3.3 Chemical analysis 
    Tape-strip samples were analyzed by gas chromatography-mass spectrometry (GC-MS).  A 
Thermoquest Trace GC (Thermo Electron Corporation, Austin, TX) coupled with a Combi Pal 
autosampler (CTC Analytics, Zwingen, Switzerland) and a Finnigan Polaris Q quadrupole ion trap MS 
(Thermo Electron Corporation, Austin, TX) in electron ionization mode, was used for the chemical 
analysis.  Separation of the sample was done with a fused-silica capillary column, 30 m × 0.25 mm 
internal diameter, coated with a mixture of 5% diphenyl:95% dimethyl polysiloxane (0.25 µm film 
thickness, RTX-5MS, Restek Corporation, Bellefonte, PA).  The oven temperature for analysis was 
40°C (3 min) and then 10°C/min to 290°C (10 min).  One µl of sample was directly injected into the 
inlet.  The ions used for quantitation were m/z 128 (naphthalene), 142 (1-methyl and 2-methyl 
naphthalene), 136 (naphthalene-d8), 71 (n-decane, n-undecane, n-dodecane), and 98 (dodecane-
d26).   
    Blood samples were analyzed using head-space solid-phase microextraction (HS-SPME) and the 
GC-MS system described above.  Modifications were made from published methods (Cardinali et al. 
2000; Waidyanatha et al. 2003).  Whole blood (1 ml) was added to a 10 ml headspace vial with crimp 
top (Microliter, Suwanee, GA) containing 3 ml of deionized water, 2 g of NaCl, and 2 µl of 5 ng/ml 
internal standard.  The vial was put into an aluminum block (CTC Analytics, Zwingen, Switzerland) for 
heating and agitating at 45ºC and 250 rpm.  After 1 min, a 100 µm polydimethyl-siloxame (PDMS) 
fiber (Supelco, Bellefonte, PA) was inserted into the head-space of the vial for 20 min.  The needle 
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containing the SPME fiber was withdrawn and introduced into the inlet of the GC for 20 min.  The inlet 
temperature was set at 230°C; an IceBlue septum (Restek, Bellefonte, PA) and a liner with an internal 
diameter of 0.8 mm (SGE, Austin, TX) were used.  All other GC-MS conditions were the same as for 
the analysis of tape-strip samples.   
 
3.3.4 Basic DTK model 
    The initial DTK model (model A) developed to study the disposition of naphthalene, 1-methyl 
naphthalene, 2-methyl naphthalene, decane, undecane, and dodecane is linear with four first-order 
rate constants and three compartments representing the surface, skin, and blood (Figure 6).  
Diffusion of chemicals across the stratum corneum is described by k0.  Thus, the rate of input to skin 
is k0 times the amount (defined as DERMDOSE) of the chemical applied to the skin: 
 
rate of input = k0 × DERMDOSE     (7) 
 
In compartmental models, the time course behavior of chemicals in each compartment is described 
by mass-balance differential equations (MBDE).  The rate constant for input of chemical in blood is k1, 
and the rate constant for efflux of chemical in the skin is k2.  The MBDE that describes the rate of 
change of the amount of chemical in skin is: 
 
ABkASkDERMDOSEk
dt
dAS
210 +−=     (8) 
 
where AS and AB are the amounts of chemical in the skin and blood respectively.  Lastly, k3 is the 
elimination rate constant.  The MBDE for blood becomes: 
 
( )ABkkASk
dt
dAB
321 +−=      (9) 
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Figure 6. Schematic of DTK models following exposures to JP-8 components: naphthalene, 1-
methyl naphthalene, 2-methyl naphthalene, decane, undecane, and dodecane.  Models A 
and B describe the skin as one compartment.  In models C and D, the skin is split into 
two compartments representing the stratum corneum and the viable epidermis.  A 
compartment for storage of chemicals is included in models B and D. 
 
 
 
3.3.5 Refined DTK model 
    The epidermis, which performs much of the barrier function of skin, is made up of two very different 
layers: the stratum corneum (SC) and the viable epidermis (VE).  The SC consists of dead cells in a 
hydrophobic environment.  The VE, on the other hand, is comprised of viable cells in a hydrophilic 
environment.  Based on these biological differences between the two main protective layers of the 
skin, two-compartment DTK models are more realistic and may predict the toxicokinetic behavior of 
chemicals better than one-compartment models.  This has been demonstrated successfully for 
dermal exposures to chemicals in an aqueous vehicle (Shatkin and Brown 1991).  In our study, two 
different two-compartment DTK models were evaluated (models C and D).  In both models, the 
diffusion of chemicals across the SC is described by k0 and diffusion across the VE is described by 
k1.   
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    Furthermore, because the aromatic and aliphatic hydrocarbons naphthalene, 1-methyl 
naphthalene, 2-methyl naphthalene, decane, undecane, and dodecane are lipophilic compounds, 
they are stored in fat tissues throughout the body.  The fat:blood partition coefficient for naphthalene 
is 160 (Willems et al. 2001) and 25 for decane (Perleberg et al. 2004).  To account for the storage of 
JP-8 components in fat, the basic DTK model was altered to include a storage compartment and 
distribution rate constants k4 (model B) and k5 (model D) and redistribution rate constants k5 (model 
B) and k6 (model D). 
 
 
Table 5. Initial values of rate constants.  Initial values were estimated by averaging values 
reported in the literature (Guy et al. 1985; Qiao et al. 2000; Williams and Riviere 1995).  
All rate constants have the units min-1. 
model k0 k1 k2 k3 k4 k5 k6 
A 0.003 1 1 0.0029    
B 0.003 1 1 0.0029 0.04 0.04  
C 0.003 0.04 1 1 0.0029   
D 0.003 0.04 1 1 0.0029 0.04 0.04 
 
 
 
 
Table 6. Experimental dose to the skin (i.e., DERMDOSE) measured in the first tape strips of 10 
study volunteers.  DERMDOSE was set to zero at the end of the exposure period. 
 
compound mean 
(µg/cm
2
) 
SD* 
(µg/cm
2
) 
ratio** 
naphthalene 216 127 1 
1-methyl naphthalene 304 102 1.4 
2-methyl naphthalene 283 91 1.3 
decane 237 213 1.1 
undecane 4033 2234 18.7 
dodecane 7277 1971 33.7 
 
* SD = standard deviation. 
** The ratio is calculated as
enaphthalen
chemical
DERMDOSE
DERMDOSE
. 
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3.3.6 Toxicokinetic analysis 
    The DTK models were formulated by simultaneously fitting the tape-strip and blood data.  
Parameters were optimized using the method of simulated annealing (Xcellon 2004).  Simulated 
annealing is a global optimization method that optimizes parameter values without being influenced 
by the initial values.  This optimization protocol is more robust than others (Goffe et al. 1994; Levitt 
2002).  However, a major limitation of simulated annealing is the longer computational time required.  
Default settings for simulated annealing were adjusted to include fewer maximum iterations (1000) 
and maximum function evaluations (5000) in order to decrease the optimization time.  Initial values of 
rate constants (Table 5) were obtained by averaging literature values (Guy et al. 1985; Qiao et al. 
2000; Williams and Riviere 1995).  The first tape strip from each study participant was treated as the 
dose to the skin (Table 6).  The baseline blood concentration was not subtracted from blood 
concentrations at t > 0 min but included as the initial concentration in the blood compartment because 
the volunteers may have had recent environmental exposures to similar compounds.  Consequently, 
baseline concentration may not be an accurate (or true) baseline since the baseline concentrations 
may decrease after breathing cleaner indoor air.  The volume of blood (Vb) was estimated using 
allometric relationships (Davies and Morris 1993).  The equation is Vb = 72.447 × (body weight in 
kg)1.007 and was used to calculate the mass of chemicals in the blood.  The baseline amount in the 
skin (AS0) compartment was calculated using the following algebraic expression: 
 
1
020
0 k
ABkDERMDOSEk
AS
+=     (10) 
 
where AB0 is the initial amount of chemical in blood.  The initial amount in the peripheral compartment 
was calculated from: 
 
for model B:  0
5
4
0 ABk
kAP =        (11) 
and for model D: 0
6
5
0 ABk
k
AP =        (12) 
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In models C and D, the initial amount in the SC was set to zero and the initial amount in the VE (AD0) 
was calculated as: 
 
0
2
3
0 ABk
k
AD =        (13) 
 
Rate constants were optimized for each study participant and results were summarized using 
descriptive statistics.  The performance of the model fit to experimental data was evaluated using a 
combination of visual inspection and statistical evaluation (Andersen et al. 2001). 
    Simulations of occupational exposure scenarios were performed using the final model.  The 
exposure scenarios were based on a field study that measured dermal exposures to naphthalene in 
the US Air Force personnel (Chao et al. 2005).  Naphthalene was used as a surrogate for JP-8 
exposure because it (1) is abundant in JP-8, (2) is readily absorbed into the blood, and (3) is only a 
minor component in confounding sources of exposure, such as cigarette smoke and gasoline exhaust 
(Rustemeier et al. 2002; Serdar et al. 2003).  The first set of simulations involved predicting the 
concentration-time profile for a specific field exposure scenario.  An average whole body (surface 
area = 2 m2) dermal exposure level of 2018 ng/m2 was used as the input in the simulations.  The 
duration of exposure was 240 minutes.  The dose to the skin was set to that of naphthalene, and 
exposure concentrations for other compounds were estimated using the ratios reported in Table 6.  
After the exposure was complete, the dose was set to zero and the simulation was continued for up to 
8 h.   
    In the second set of simulations, a Monte Carlo method was used to examine the impact of 
exposure variability on cumulative internal dose.  The geometric mean and standard deviation of the 
whole-body dermal exposure to naphthalene were 344 ± 4 ng/m2 for the low-exposure group, 483 ± 4 
ng/m2 for the medium-exposure group, and 4188 ± 10 ng/m2 for the high-exposure group.  These 
values were used to specify the input distribution functions for the simulations.  The distribution of the 
input parameters was log-normal and the number of simulations was set at 100.  The model output 
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was cumulative internal dose (DOSEc), i.e., the area under the blood concentration-time curve.  
DOSEc was calculated by integrating the blood concentration for the duration of the simulation:   
 
dt)t(CDOSE
1t
0t
bc ∫=       (14) 
 
where t0 was the time at the start of the simulation, t1 was the time at the end of the simulation, and 
Cb(t) was the concentration of the chemical in blood. 
 
3.4 Results 
3.4.1 Model selection: visual inspection 
    Simulations of the blood concentrations of naphthalene, 1-methyl naphthalene, 2-methyl 
naphthalene, decane, undecane, and dodecane were compared to experimentally measured blood 
concentrations in individual study volunteers.  One of the volunteers was a 23-year old Caucasian 
male with a BMI of 25 kg/m2 (Figure 7).  For this individual, the maximum concentrations (Cmax) in 
blood occurred shortly after the end of exposure (tmax ≈ 30 min) for all chemicals but dodecane, which 
occurred at tmax ≈ 60 min.  The peak concentrations were 0.8 ng/ml, 0.5 ng/ml, 1 ng/ml, 3.5 ng/ml, 1.8 
ng/ml, and 3.3 ng/ml for naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, decane, 
undecane, and dodecane respectively.  Cmax was sustained for up to t = 100 min for decane and 
dodecane.  The blood concentrations of all chemicals at t > 0 min did not return to baseline levels.  
The models B and D seemed to fit naphthalene and 1-methyl naphthalene data the best; all models fit 
the 2-methyl naphthalene time course equally well.  For the aliphatic components, no model stood out 
as being superior to others, although model A seemed to fit the dodecane data the best.  None of the 
models were able to predict the sustained blood concentration observed in the dodecane time course.   
    The simulations and the observed data for the individual discussed above were compared to 
results from a different individual (Figure 8).  This individual was a 24-year old Caucasian female with 
a BMI of 22 kg/m2.  The toxicokinetic behavior of aromatic and aliphatic hydrocarbons was very 
different for this volunteer.  The peak concentrations occurred at tmax ≈ 60 min for naphthalene (Cmax = 
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0.3 ng/ml), at tmax ≈ 100 min for 1-methyl naphthalene (Cmax = 0.3 ng/ml), and at tmax ≈ 60 min for 2-
methyl naphthalene (Cmax = 0.3 ng/ml); peak concentrations for all aliphatic components occurred at 
tmax ≈ 30 min.  The Cmax were 2.5 ng/ml, 1.2 ng/ml, and 3.5 ng/ml for decane, undecane, and 
dodecane respectively.  Concentrations in blood at t > 0 min did not reach baseline levels for aromatic 
components; however, concentrations at t > 0 min did reach baseline concentrations for the aliphatic 
components.  Model C seemed to fit the naphthalene data the best.  Models A, C, and D fit 2-methyl 
naphthalene data equally well.  Model fits to 1-methyl naphthalene data were poor.  For the aliphatic 
components, model D fit most datasets; however, the peak concentration for decane was not 
predicted by any of the models. 
 
3.4.2 Model selection: statistical evaluation 
    In addition to the visual inspection of model predictions and time-course data, a likelihood ratio 
(LR) test was used to provide a statistically rigorous comparison of the models (Andersen et al. 2001; 
Pinheiro and Bates 2000).  One model is said to be nested within another model if it represents a 
special case of that model.  If L2 is the maximum likelihood of the model with additional parameters, 
and L1 is the maximum likelihood of the model with fewer parameters, then L2 > L1 and, 
correspondingly, log L2 > log L1.  The LR test statistic is: 
 
LR test statistic = 2 × (log L2 – log L1)    (15) 
 
The LR test statistic is compared to a χ2f,α distribution with f degrees of freedom.  The p-value is 
compared to α, which is the significance level for accepting or rejecting the null hypothesis.  All 
models were compared to model A at a significance level of α = 0.1.  With the addition of a storage 
compartment (model B), two additional degrees of freedom were introduced (k4 and k5).  Splitting the 
skin compartment into the SC and VE (model C) introduced 1 more degree of freedom (k1).  Model D 
introduced three more degrees of freedom as a result of splitting the skin and addition of a storage 
compartment (k1, k5, and k6).  Overall, model B resulted in significantly improved fits to the data for 
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15% of the study volunteers.  When models C and D were compared to model A, 25% and 40% of 
the volunteers had improved fits, respectively. 
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Figure 7. Time-course plots of fitted and observed blood concentrations of aromatic components of 
JP-8 for study volunteer 1.  Shown are observed data ( ■ ), model A (----),  model B (- - - ), 
model C (------), and model D (------). 
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Figure 8. Time-course plots of fitted and observed blood concentrations of aromatic components of 
JP-8 for study volunteer 2.  Shown are observed data ( ■ ), model A (----), model B (- - - ), 
model C (-----), and model D (-----).  The y-axis is adjusted (range 0.2 ng/ml to 0.4 ng/ml) for 
better visualization of model predictions and data for aromatic compounds. 
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    Based on both visual inspection and statistical evaluation of the models, model D was selected as 
the model that best fit the kinetic data.  The optimized rate constants for aromatic and aliphatic 
components are reported in Table 7.  Some interesting patterns were observed.  First, k0 is 4 orders 
of magnitude smaller than k1.  This was expected since the SC is the rate limiting barrier to 
hydrophobic compounds, which are not as limited by the VE.  Second, the distribution rate constant k5 
is larger than the redistribution rate constant k6, which is consistent with the expected properties of 
the storage compartment.  Finally, the elimination rate constant k4 is consistently larger for aliphatic 
components.   
 
 
Table 7. Optimized rate constants for model D.  The average rate constants from all subjects are 
shown.  The method of simulated annealing was used to optimize each rate constant.  
The units for all rate constants are min-1. 
 Naphthalene 1-Methyl  Naphthalene 2-Methyl Naphthalene 
 mean SD mean SD mean SD 
k0 4.1x10
-4
 8.4x10
-4
 7.8x10
-5
 5.8x10
-5
 2.5x10
-4
 4.2x10
-4
 
k1 1.9 1.6 1.0 1.5 1.2 0.9 
k2 35 30 10 19 30 33 
k3 43 26 29 24 42 34 
k4 0.04 0.04 0.04 0.04 0.04 0.04 
k5 1.4 1.0 1.9 1.0 0.8 0.6 
k6 0.10 0.07 0.13 0.10 0.11 0.12 
 Decane Undecane dodecane 
 mean SD mean SD mean SD 
k0 6.9x10
-4
 7.6x10
-4
 1.6x10
-4
 3.3x10
-4
 7.9x10
-5
 1.3x10
-4
 
k1 1.9 0.9 1.9 1.2 1.9 1.3 
k2 42 28 59 39 48 38 
k3 51 31 62 35 55 29 
k4 0.13 0.05 0.09 0.05 0.10 0.07 
k5 1.6 0.9 1.8 1.1 2.0 0.7 
k6 0.15 0.10 0.07 0.09 0.07 0.06 
 
SD = Standard Deviation 
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3.4.3 Simulations of dermal exposures to JP-8 
    Simulations of whole body dermal exposure to JP-8 were conducted to examine the toxicokinetic 
behavior of aromatic and aliphatic components of JP-8 under an occupational exposure setting 
(Figure 9).  The parameters for the simulations were an exposure duration of 240 minutes (4 hours) 
and dermal exposure to 2018 ng/m2 of naphthalene for a 70 kg person.  After the end of 240 min 
exposure, the simulations were extended for an additional 4 hours.  Since dermal exposures to other 
components were not measured by Chao et al. (2005), exposures to 1-methyl naphthalene, 2-methyl 
naphthalene, decane, undecane, and dodecane were estimated using the ratios reported in Table 6.  
The model-predicted Cmax were 3.6 × 10-3 ng/ml, 8.6 × 10-4 ng/ml, 3.9 × 10-3 ng/ml, 4.1 × 10-3 ng/ml, 
1.4 × 10-2 ng/ml, and 1.1 × 10-2 ng/ml for naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, 
decane, undecane, and dodecane, respectively.  All peak concentrations occurred at tmax = 240 min.  
The model predictions of blood concentration of all components drop sharply at the end of the 
exposure.  The concentrations at the end of the simulation were 54%, 58%, 37%, 10%, 44%, and 
44% of Cmax for naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, decane, undecane, and 
dodecane respectively. 
    The mass of aromatic and aliphatic components of JP-8 in the SC, VE, and storage compartments 
were predicted to characterize the toxicokinetic behavior of these compounds (Figure 10).  In these 
simulations, naphthalene and decane were treated as chemical tracers for the aromatic and aliphatic 
hydrocarbons, respectively.  Predictions were made for the same simulation conditions as described 
above.  The SC achieved a steady state while the other compartments did not.  In the storage 
compartment, the ratio of mass at t = 8 h to the mass at tmax is 56% and 10% for aromatic and 
aliphatic components, respectively.  Conversely, the ratios are 53% and 9% for aromatic and aliphatic 
components in the VE, respectively, and 0% for both aromatic and aliphatic components in the SC. 
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Figure 9. Simulated blood concentration profiles of aromatic and aliphatic components from dermal 
exposure to JP-8.  Predictions were made using model D.  The mean exposure to 
naphthalene was 2018 ng/m2.  The simulation was for a 70 kg person exposed over a 
whole body surface area of 2 m2.  Simulations were run for one full 8 h work day with an 
exposure duration of 240 min.  The concentration of 1-methyl naphthalene, 2-methyl 
naphthalene, decane, undecane, and dodecane were estimated using the ratios from 
Table 2. 
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Figure 10. Simulation results of the mass of aromatic (i.e., naphthalene) and aliphatic (i.e., 
decane) components of JP-8 in the stratum corneum (SC), viable epidermis (VE) and 
the storage compartment.  Predictions were made using model D.  Dermal exposures 
to naphthalene and decane were set at 2.0 µg/m2 and 2.2 µg/m2 respectively.  The 
duration of dermal exposure was 4 h and the simulations were carried out to 8 h.  
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3.4.4 Dermal Exposure variability 
    Monte Carlo methods were used to examine the distribution of the cumulative internal dose 
(DOSEc) for naphthalene in blood resulting from variability of dermal exposure levels in the low-, 
medium-, and high-exposure groups.  The input parameters were the geometric mean and standard 
deviation of the whole-body dermal exposure to naphthalene.  These were 344 ± 4 ng/m2 for the low-
exposure group, 483 ± 4 ng/m2 for the medium-exposure group, and 4188 ± 10 ng/m2 for the high-
exposure group.  The distribution of the input parameters was specified as log-normal and 100 
iterations were performed (Table 8).  The DOSEc for naphthalene at all exposure levels was normally 
distributed and did not intersect one another.  Further simulations of daily 4 h exposure to low, 
medium, and high levels of naphthalene were conducted to examine the time course profiles of 
naphthalene in blood from repeated exposures (Figure 11).  The DOSEc for low, medium, and high 
dermal exposures are 1.6 ng·h/ml, 2.3 ng·h/ml, and 19.6 ng·h/ml, respectively. 
 
 
Table 8. Results of Monte Carlo analysis of whole body dermal exposure to naphthalene in JP-8.  
The dermal exposure distribution was specified as log-normal and 100 simulations were 
run.  Model D was used for these simulations.  Exposure concentrations were obtained 
from Chao et al. (2005).  Reported is geometric mean ± SD. 
 
Exposure level Dermal exposure to 
naphthalene (ng/m
2
) 
AUC (ng·min/ml) Exposure level 
low 344 ± 4 1.61 ± 0.02 low 
medium 483 ± 4 2.26 ± 0.02 medium 
high 4188 ± 10 19.56 ± 0.05 high 
 
 AUC = area under the curve 
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Figure 11. Simulations of the blood concentrations of naphthalene resulting from dermal 
exposures to JP-8.  Predictions were made using model D.  The length of each 
simulation was 5 days and the duration of exposures was for 4 hours each day.  The 
DOSEc for low, medium, and high dermal exposures are 1.6 ng·h/ml, 2.3 ng·h/ml, and 
19.6 ng·h/ml, respectively. 
 
 
3.5 Discussion 
    Chemicals deposited on the skin can evaporate from the surface, be absorbed into deeper layers 
of the skin, be metabolized, or penetrate the skin for distribution to other tissues.  Understanding the 
fate of chemicals deposited on the skin is an important step in assessing the associated risks.  
Therefore, the current study presents a DTK model that can be used to quantify the toxicokinetic 
behavior of chemicals following dermal exposure to a complex chemical mixture such as JP-8.  This 
study represents the first attempt at deriving toxicokinetic parameters for dermal exposure to JP-8 in 
humans. 
    In the current study, a two-compartment model of the skin was developed and parameters 
estimated for dermal exposure to JP-8.  We found that, although the one-compartment models fit 
some observed data, a two-compartment model of the skin fit the data better from all 10 study 
volunteers.  In our model, the two compartments represented the SC and VE, thus representing a 
more biologically plausible description of the skin.  Physiologically, the SC and VE have very different 
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physical characteristics, primarily in that the SC is hydrophobic and the VE is hydrophilic.  Our 
estimates of k0 and k1 supported the two-compartment model structure; k0 was 4 orders of magnitude 
less than k1, suggesting slower diffusion across the SC than the VE.  This was not unexpected since 
the SC is rate-limiting for the absorption of chemicals into deeper skin layers, and for penetration of 
chemicals into the blood.  It is well known that non-polar chemicals with small molecular weights 
move across the SC by passive diffusion through a lipid matrix between protein filaments.  The VE, 
however, consists of an aqueous medium with proteins that may be involved in metabolism and 
active transport of compounds into the systemic circulation.  The rate of transport across the VE is 
dependent on blood flow, interstitial fluid movement, and interaction with VE constituents.  
Conversely, the rate of transport of a chemical across the SC is dependent on the thickness of the 
SC, the concentration gradient, level of hydration, and the diffusion coefficient of the compound. 
    The penetration of chemicals across the skin is quantified experimentally using diffusion cells and 
dermatomed skin from rats and pigs (McDougal et al. 2000; McDougal and Robinson 2002; 
Muhammad et al. 2004; Sartorelli et al. 1998).  In these experiments, the chemical of interest is 
applied to a donor cell and the receptor compartment is sampled at different time points.  The 
cumulative quantity of chemical collected in the receptor compartment is plotted as a function of time.  
The flux value is obtained from the slope of the cumulative amount of chemical permeated vs. time 
plot.  Apparent permeability coefficient (Kp) values are computed using the following expression 
(McDougal and Boeniger 2002): 
 
J = Kp × C      (16) 
 
where J is the flux (mass/area/time) and C is the concentration of chemical in the donor cell 
(mass/volume).  Flux values are determined in vitro typically under steady-state conditions, i.e. when 
the concentration of chemical in the donor compartment is constant over time (Bronaugh and 
Maibach 1999; McDougal and Boeniger 2002); however, steady-state conditions are difficult to 
maintain experimentally in vivo.  Previously, the flux value was estimated for aromatic and aliphatic 
components of JP-8 in humans from the slope of the linear portion of the cumulative mass of 
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chemical in blood per cm2 vs. time curve (Kim et al. 2006).  Kp was calculated using equation 16.  
This calculation did not take into account the mass in the storage compartment and the mass cleared 
from the blood, and therefore, underestimated Kp.  Here, we have revised our previous estimates of 
Kp using the final DTK model.  The rate of input in this DTK model is equivalent to the product of the 
permeability coefficient (Kp), the exposed surface area (Aexp), and the concentration of the chemical 
component in JP-8 (CJP-8) (McCarley and Bunge 2001; McDougal and Boeniger 2002): 
 
rate of input = k0 × DERMDOSE = Kp × Aexp × CJP-8   (17) 
 
Equation 17 can be rearranged to solve for Kp: 
 
Kp = 
8JPexp
0
CA
DERMDOSEk
−×
×
      (18) 
 
Using equation 18, we calculated Kp values of 1.8×10-3 cm/h, 1.3×10-3 cm/h, 3.5×10-4 cm/h, 3.5×10-4 
cm/h, and 3.3×10-3 cm/h for naphthalene, 1- and 2-methyl naphthalene, decane, undecane, and 
dodecane, respectively.  The revised estimates of Kp were more than an order of magnitude larger 
than the values reported previously (Kim et al. 2006) but within an order of magnitude reported by 
McDougal et al. (2000).  These results suggest that reasonable estimates of the permeability 
coefficient for aromatic and aliphatic components of JP-8 may be derived from in vitro studies. 
    Although the stratum corneum is the main rate-limiting barrier for the penetration of chemicals, the 
viable epidermis can also affect the amount of parent compound available for systemic circulation by 
binding chemicals and/or metabolizing them to a more water-soluble form.  Although we did not 
include skin metabolism in our DTK model, we quantified the disposition of chemicals in the VE.  The 
net rate of change of the amount of chemical in the VE depends on the rate of input from the SC, rate 
of efflux to the systemic circulation, and rate of input from the systemic circulation.  Therefore, the 
MBDE for the VE is: 
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ABkAEkASk
dt
dAE
321 +−=      (19) 
 
where AE is the amount of chemical in the VE.  The rate constants k2 and k3 in equation 19 have 
been represented in terms of the physicochemical and physiological properties of the skin (McCarley 
and Bunge 2001).  The rate constant k2 has been expressed as Qve/(Vve × Pve:b) where Qve is the 
volumetric flow rate to the exposed area of skin, Vve is the volume of the exposed VE,  and Pve:b is the 
solubility of the chemical in the blood relative to the VE, i.e., VE:blood partition coefficient.  The rate 
constant k3 is represented as Qve/Vb.  Rearranging, Pve:b therefore equals (Vb/Vve) × (k3/k2).  Using this 
expression, we estimated an average Pve:b of 5 for aromatic compounds and 3 for aliphatic 
compounds.  The Pve:b for 1-methyl naphthalene was larger than other components of JP-8; when this 
value was taken out of the calculation, we estimated a Pve:b of 3 also for the aromatic components.  
Our estimates were similar to Pve:b reported in the literature.  McCarley and Bunge (2001) calculated 
Pve:b using the following equation: 
 
owb,fatb,fat
owve,fatve,fat
b:ve Kf)f1(
Kf)f1(
P +−
+−=      (20) 
 
where ffat,ve and ffat,b are the fractions of fat in the VE and blood respectively, and Kow is the 
octanol:water partition coefficient.  Using equation 15, ffat,ve = 0.02, and ffat,b = 0.007, the predicted 
value of Pve:b was 3 for all aromatic and aliphatic hydrocarbons examined in our study.  The 
consistency between estimating Pve:b using equation 15 and the values that we report in our study 
give confidence to our findings. 
    Another major change we made to the basic DTK model was the addition of a storage 
compartment.  JP-8 is a mixture of lipophilic hydrocarbons, which suggests that sequestration of JP-8 
components in fat stores throughout the body is very likely.  Chemicals are stored in fat by dissolution 
in neutral fats, which constitute from about 20 – 50% of the body weight (Klaassen 1996).  Thus, 
considerable amounts of chemicals with high fat:blood partition coefficients will be stored in body fat.  
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Also, blood proteins such as albumin can bind with chemicals and serve as a depot protein.  Further, 
the liver and kidneys both have a high capacity for metabolism and/or binding chemicals before 
elimination by active transport (Klaassen 1996).  Few DTK models have included a storage 
compartment for toxicants.  Qiao et al. (2000) included a storage compartment to quantify the 
toxicokinetic behavior of p-nitrophenol in swine using a 12-compartment model.  They found that the 
peripheral compartment was able to store a constant amount of p-nitrophenol, and the excess was 
redistributed to the systemic circulation for elimination.  In our study, simulations of dermal exposure 
to JP-8 showed that the storage capacity of the SC compared to the VE is small, while as expected, 
the storage compartment is a larger reservoir for exogenous chemicals. 
    For the six aromatic and aliphatic components of JP-8 that we examined in our study, there are 
three significant clearance pathways: metabolism, exhalation, and urination.  Urinary clearance is not 
considered to be a major pathway for chemicals with high Kow since they will be reabsorbed efficiently 
through the tubular cells of the nephron back into the systemic circulation.  The metabolic clearance 
of all the components of JP-8, mostly from the liver, is not well understood.  The metabolism of 
naphthalene, however, has been studied extensively (ATSDR 1995; Buckpitt and Bahnson 1986; US 
EPA 1998).  Phase I metabolism of naphthalene involves oxygenation by the cytochrome P450 
monooxygenases (e.g., CYP 1A1) to naphthalene-1,2-oxide.  This epoxide rearranges to 1- or 2-
naphthol or undergoes phase II reactions to form more water-soluble compounds for eventual urinary 
clearance.  The metabolism of aliphatic components, such as dodecane, is not well understood, but 
they are thought to undergo oxidation reaction to a ketone through an intermediate hydroxylation step 
(Subcommittee on Jet-Propulsion Fuel 8 2003).  Clearance by exhalation is the other major loss 
mechanism for volatile organics.  Pulmonary clearance can be approximated by cardiac output times 
the ratio 1 / (1+Pb:a) where Pb:a is the blood:air partition coefficient (Andersen et al. 2001).  For 
naphthalene (Pb:a ≈ 571), pulmonary clearance is 0.2% of cardiac output whereas for decane (Pb:a ≈ 
5) it is 16%.  The difference in pulmonary clearance between the aromatic and aliphatic components 
may explain the difference in estimates of k4 between aliphatic (k4 = 0.11 min-1) and aromatic (k4 = 
0.04 min-1) components of JP-8. 
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    We constructed and evaluated a DTK model based on empirical data that may be used to quantify 
the absorption, distribution, and elimination of aromatic and aliphatic compounds following dermal 
exposure to JP-8.  The final optimized model was used to simulate the time-course of naphthalene 
and other components of JP-8 using information collected in an occupational exposure assessment 
study (Chao et al. 2005; Chao et al. 2006).  We observed that the predicted cumulative internal dose 
was distinctly different among low-, medium-, and high-exposure groups.  This supports the 
hypothesis that dermal exposure measurements made by tape-strip sampling may be used in 
exposure assessment studies.  We note that biological variability will introduce more variation into the 
distribution of DOSEc.  In our study, we could not examine inter- and/or intra-individual variation in the 
disposition of JP-8 components due to the limited sample size.  Further study is required to better 
estimate inter- and intra-individual variability in exposure measurements for different work processes.  
We have described here a DTK model that will be useful for the development of a toxicokinetic 
modeling strategy for multi-route exposures to jet fuel in humans. 
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4.1 Abstract 
    Occupational exposure studies have measured dermal and inhalation exposures to jet-propulsion 
fuel type 8 (JP-8); however, a quantitative understanding of the contribution of external exposure to 
internal dose is lacking for occupational and environmental exposure scenarios.  We constructed a 
physiologically based toxicokinetic (PBTK) model, which accurately describes the disposition of 
naphthalene, a prominent aromatic constituent of JP-8, in humans.  We then estimated the relative 
contributions of dermal and inhalation exposures to the systemic levels of naphthalene.  The PBTK 
model consisted of five compartments representing the stratum corneum, viable epidermis, blood, fat, 
and other tissues.  The parameters were optimized using exclusively human exposure and biological 
monitoring data.  The optimized values of parameters for naphthalene were (1) blood:air partition 
coefficient = 27.1, (2) fat:blood partition coefficient = 40.4, (3) permeability coefficient for the stratum 
corneum = 5.2×10-5 cm/h, (4) stratum corneum:viable epidermis partition coefficient = 12.7, and (5) 
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permeability coefficient for the viable epidermis = 2.0 cm/h.  The estimated permeability coefficient 
was comparable to the values estimated from in vitro studies.  Based on simulations of worker’s 
exposures to JP-8 during aircraft fuel-cell maintenance operations, the median relative contribution of 
dermal exposure to the internal dose of naphthalene was 1.7% (10th percentile = 0.3% and 90th 
percentile = 6.9%).  PBTK modeling allowed contributions of the systemic dose of naphthalene, an 
important JP-8 constituent, to be partitioned between dermal and inhalation routes of exposure.  The 
model also pointed to the need for further exposure assessment to provide data with which to better 
characterize the toxicokinetic behavior of JP-8 components following occupational and environmental 
exposures. 
 
4.2 Introduction 
    The single largest source of chemical exposure on military bases of the North Atlantic Treaty 
Organization (NATO) is jet-propulsion fuel 8 (JP-8), which is the preferred fuel for both aircraft and 
military vehicles in NATO countries.  JP-8 is composed of many aromatic hydrocarbons, including 
benzene and naphthalene, and aliphatic hydrocarbons such as nonane and decane (McDougal et al. 
2000).  Exposures to JP-8 can occur during spills, transportation and storage of the fuel, as well as 
fueling, general maintenance and operation of aircraft and military vehicles, fueling of military tent 
heaters, and cleaning and degreasing of parts with the fuel.   
    Since JP-8 can enter the body via both inhalation and dermal contact, the assessment of 
occupational exposures to fuel constituents can be difficult.  Personal sampling of JP-8 vapors 
provides information about levels in the breathing zone but not from dermal contact.  Likewise 
sampling the exposed skin provides information about dermal contact but not inhalation.  The 
collection of end-exhaled breath concentrations, on the other hand, provides an integrated estimate of 
uptake via both inhalation and dermal contact (Egeghy et al. 2003; Pleil et al. 2000) but cannot 
determine the relative contributions of the two exposures routes to the internal dose.  Through 
statistical evaluation of levels of naphthalene in air, breath and skin, measured in Air Force personnel 
during fuel maintenance procedures, Chao et al. (2006) demonstrated that both inhalation and dermal 
exposures to JP-8 contributed to the internal dose.  However, given the use of respiratory protection 
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in that population, it was difficult to determine the relative contributions of dermal and inhalation 
exposures to the systemic levels of JP-8 components. 
    Physiologically based toxicokinetic (PBTK) modeling is an effective tool for quantifying the 
absorption, distribution, metabolism, and elimination of chemicals.  PBTK models have been 
developed for various components of JP-8, notably naphthalene and decane (Perleberg et al. 2004; 
Quick and Shuler 1999; Willems et al. 2001)  The model developed by Quick and Shuler (1999) 
focused upon the disposition of naphthalene in five compartments representing the lungs, liver, fat, 
rapidly perfused tissues, and slowly perfused tissues and relied upon in vitro data to calibrate kinetic 
constants.  Willems et al. (2001) refined the Quick and Shuler (1999) model by using kinetic 
constants derived from in vivo data from laboratory animal experiments performed by the National 
Toxicology Program.  They observed that a diffusion-limited PBTK model was necessary to 
characterize the toxicokinetic behavior of naphthalene in rats and mice.  Perleberg et al. (2004) 
developed a PBTK model using decane as a chemical marker of JP-8.  Data for calibration and 
validation of this model was derived from an animal study where rats were exposed for 4 h to decane 
vapor at three different concentrations: 1200 ppm, 781 ppm, or 273 ppm.  Their final model consisted 
of flow-limited compartments for liver and lung, and diffusion-limited compartments for the brain, bone 
marrow, fat, skin, and spleen.  The model was used to adequately predict the time course of decane 
in tissue and blood from low-level exposures to decane vapor. 
    Since the PBTK models mentioned above did not examine the uptake via dermal exposure, we 
developed a PBTK model, which included both inhalation and dermal sources of exposure.  
Naphthalene was chosen as the surrogate for JP-8 exposure because it is abundant in JP-8, is 
readily absorbed into blood, and is only a minor component in confounding sources of exposure, such 
as cigarette smoke and gasoline exhaust (Rustemeier et al. 2002; Serdar et al. 2003).  The model 
was calibrated with concentrations of naphthalene measured in the skin, in the personal breathing 
zone air, and in the end-exhaled breath samples of US Air Force personnel (Chao et al. 2005; 
Egeghy et al. 2003) and in a study of controlled dermal exposure in humans (Kim et al. 2006).   
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4.3 Methods 
4.3.1 Laboratory study of dermal exposure to JP-8 
    A laboratory study was conducted to quantify the dermal absorption and penetration of JP-8 
components across human skin in vivo (Kim et al. 2006).  Ten volunteers (five females and five 
males) were recruited for this study.  Briefly, exposures were conducted in an exposure chamber 
(20.3 cm width × 20.3 cm length × 18.8 cm height and a total volume of 7706 cm3).  One forearm was 
placed palm up inside the exposure chamber, and two aluminum application wells were pressed 
against the skin and sealed for the duration of the experiment (0.5 h).  At the end of the 0.5 h 
exposure period, the exposed sites were tape-stripped 10 times with adhesive tape strips (Cover-
RollTM tape; Beiersdorf, Germany).  Blood samples were drawn from the unexposed arm at baseline, 
0.5, 1, 1.5, 2, 2.5, 3, and 3.5 h.  Both tape-strip and blood samples were analyzed by gas 
chromatography mass spectrometry (GC-MS).  The time course of naphthalene in blood for all study 
volunteers showed considerable inter-individual variability.  For example, the time course for a 23-
year-old Caucasian male with a body mass index (BMI) of 25 kg/m2 was very different from a 24-year-
old Caucasian female with a BMI of 22 kg/m2.  For the male volunteer, the maximum concentrations 
in blood (Cmax) occurred shortly after the end of exposure (tmax ≈ 30 min) with a value of 0.8 ng/ml.  
The Cmax for the female volunteer occurred at tmax ≈ 60 min with a value of 0.3 ng/ml.  In either case, 
the concentrations in blood at t > 0 min did not reach baseline levels. 
 
4.3.2 Field study of dermal and inhalation exposures to JP-8 
    Exposure data was obtained from the assessment of dermal and inhalation exposures to JP-8 in 
the personnel at six US Air Force bases in the continental US (Chao et al. 2005; Egeghy et al. 2003).  
The duration of exposure was approximately 4 h.  The concentration of naphthalene in the personal 
breathing zone air (referred to as air concentration from here on) was measured using passive 
monitors (Egeghy et al. 2003).  End-exhaled breath samples were collected pre- and post-exposure 
(Egeghy et al. 2003).  Both air and breath samples were analyzed by gas chromatography with 
photoionization detection.  Dermal samples were collected post-exposure using adhesive tape strips 
with dimensions of 2.5 cm × 4.0 cm (surface area 10 cm2) from exposed body regions including the 
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forehead, neck, shoulders, arms, hands, legs, knees, feet, and buttocks (Chao et al. 2005).  All tape-
strip samples were extracted with acetone and analyzed by gas chromatography-mass spectrometry. 
    The median air concentrations of naphthalene in air samples were 1.9 µg/m3 (range: <1.0 - 16.9 
µg/m3), 29.8 µg/m3 (range: <1.0 - 932 µg/m3), and 867 µg/m3 (range: 12.8 - 3910 µg/m3) for the low-, 
medium-, and high-exposure groups, respectively (Egeghy et al. 2003).  The median pre-exposure 
breath levels of naphthalene were <0.5 µg/m3 (range: <0.5 – 36.3 µg/m3), <0.5 µg/m3 (range: <0.5 - 
16.1µg/m3), and <0.5 µg/m3 (range: <0.5 - 6.1 µg/m3) for the low-, medium-, and high-exposure 
groups.  The median post-exposure breath levels were 0.73 µg/m3 (range: <0.5 - 6.9 µg/m3), 0.93 
µg/m3 (range: <0.5 - 13.0 µg/m3), and 1.83 µg/m3 (range: <0.5 - 15.8 µg/m3) for the low-, medium-, 
and high-exposure groups, respectively.  The corresponding median concentrations of dermal 
samples were 344 ng/m2 (range: 159 - 54 200 ng/m2), 483 ng/m2 (range: 150 - 13 200 ng/m2), and 
4188 ng/m2 (range: 100 - 4 880 000 ng/m2) in the low-, medium-, and high-exposure groups (Chao et 
al. 2005).   
 
4.3.3 Description of the PBTK model 
    A dermatotoxicokinetic (DTK) model, which was previously developed for describing the disposition 
of aromatic and aliphatic components of JP-8 following controlled dermal exposure (Kim et al. 
submitted), formed the basis of the PBTK model (Figure 12).  The DTK model consisted of five 
compartments representing the surface, stratum corneum, viable epidermis, blood, and storage 
tissues.  The parameters for the DTK model were estimated by fitting the model to the data.  The 
major difference between the DTK and the PBTK model structures is that the storage compartment 
was split into fat and all other tissues.  The rationale behind defining the storage compartment in this 
fashion was based on the high fat:blood partition coefficient (Pf:b) of naphthalene (160), which is more 
than five times the partition coefficient of the other tissues (Fiserova-Bergerova 1983).  Further 
additions to the PBTK model included pulmonary uptake and clearance.  All compartments in the 
PBTK model corresponded to the actual anatomy and physiology of humans.  The skin compartments 
were composed of the skin directly under the exposed area.  All tissues were perfusion limited and 
well-mixed.  Absorbed naphthalene was distributed to other tissue compartments at a rate equal to 
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the blood flow rate to that tissue.  Naphthalene was stored in the fat and other tissue compartments 
based on the physiological parameters of that compartment, i.e., tissue:blood partition coefficient, 
tissue volume, and blood perfusion rate.   
    Most physiologically based compartmental models separate the arterial blood from the central 
venous blood.  Data based compartmental models treat the blood as one compartment.  Also in data 
based compartmental models, the peripheral compartments represent organs or tissues that, being 
poorly perfused with blood, are in slower equilibrium distribution with blood.  Blood samples were 
collected from the antecubital vein in the study by Kim et al. (2006).  The antecubital vein drains blood 
from the hand and the superficial layers of the forearm.  The concentration of solute in the antecubital 
vein is different from the concentrations of solute in the arterial and central venous blood (Levitt 
2004).  However, the blood in the antecubital vein is in rapid equilibrium with arterial and central 
venous blood relative to the fat and other tissue compartments.  Therefore, we treated the arterial and 
central vein as a single compartment, and approximated the concentration of naphthalene in the 
central (i.e., blood) compartment using measurements made from the antecubital vein. 
    Two routes of exposure were modeled: dermal and inhalation.  Pulmonary uptake is equal to the 
ventilation rate (QP) times the concentration of naphthalene in the personal breathing zone (CPBZ): 
 
Pulmonary uptake = QP × CPBZ     (21) 
 
In equation 21, rapid equilibration of naphthalene takes place across the alveolar lining, and neither 
storage nor metabolism in the lungs appreciably affects the uptake of naphthalene into the systemic 
circulation.  Since arterial, lung, and venous blood are treated as a combined blood compartment, the 
rate of absorption is equal to pulmonary uptake.  Dermal absorption and penetration is modeled as a 
one-directional diffusive process according to Fick’s first law of diffusion.  As such, the diffusion of 
naphthalene across the stratum corneum (SC) and the viable epidermis (VE) are quantified using 
permeability coefficients, the area of exposure, and the thickness of the membrane (McCarley and 
Bunge 2001; McDougal and Boeniger 2002).  The rate of efflux from the SC to the VE is dependent 
on the solubility of naphthalene in the SC relative to the VE.  Therefore, the rate of efflux of 
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naphthalene from the SC to the VE is equal to Kpv×Aexp×CD/PD, where Kpv is the permeability 
coefficient across the VE, CD is the concentration in the SC, Aexp is the exposed surface area, and 
Psc:ve is the SC:VE partition coefficient.  The mass balance differential equation (MBDE) for the SC is: 
 
CDA
P
K
DERMDOSEK
dt
dAD
exp
ve:sc
pv
uptake −=     (22) 
 
where Kuptake is the input rate constant and DERMDOSE is the dose to the skin.  The rate of input 
from blood to VE is the cutaneous blood flow rate (QE) times the concentration of naphthalene in 
blood (CB), and the rate of efflux from the VE to blood is controlled by QE and the solubility of 
naphthalene in the blood (Pve:b).  The MBDE for the amount of naphthalene in the VE is: 
 
⎟⎟⎠
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⎛ −+=
b:ve
exp
ve:sc
pv
P
CECBQECDA
P
K
dt
dAE     (23) 
 
where AE is the amount and CE is the concentration of naphthalene in the VE. 
    Elimination of naphthalene proceeds by two significant mechanisms: exhalation and metabolism.  
The concentration of naphthalene in end-exhaled air is equal to the blood concentration divided by 
the blood:air partition coefficient (Pb:a).  Pulmonary clearance of naphthalene is the ventilation rate 
(QP) divided by Pb:a.  Metabolism of naphthalene occurs in the liver by a single metabolic pathway 
following first-order kinetics.  The initial step in naphthalene metabolism is the formation of 
naphthalene-1,2-oxide by cytochrome P450 monooxygenases (ATSDR 1995).  Liver clearance (ClL) 
is: 
 
⎟⎟⎠
⎞
⎜⎜⎝
⎛
+= QLK/V
K/V
QLCl
Mmax
Mmax
L      (24) 
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where Vmax (mg/min) is the maximum rate of metabolism, KM (mg/L) is the Michaelis-Menten constant, 
and QL the blood flow rate to the liver (L/min).  The ratio of liver clearance to liver blood flow is the 
extraction ratio (EL) where EL is: 
 
   
QLK/V
K/V
E
Mmax
Mmax
L +=        (25) 
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Figure 12. Schematic of the (A) dermatotoxicokinetic (DTK) and (B) physiologically based 
toxicokinetic (PBTK) models for the study of naphthalene toxicokinetics.  Pulmonary 
uptake of naphthalene in the personal breathing zone and pulmonary clearance from 
the blood compartment are added to the DTK model. 
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Table 9. Naphthalene PBTK model parameters. 
 
Parameter Symbol Units Value Notes and References 
Body weight BW kg 61 Kim et al. (in press) 
Height HT cm 174 Kim et al. (in press) 
Body mass index BMI kg/m2 20 BMI = BW / HT2 
Organ volumes     
Blooda Vb L 4.5 BW = (72.447/1000) × BW1.007 
Stratum corneum Vsc L 2×10-5 VD = Aexp × Td 
Viable epidermisb Vve L 1.9×10-3 VE = VEC × BW – VD 
Fatc Vf L 5.5 VF = BW × (ln BMI – 126.2)/100 
Other tissue Vo L 51.0 VO = BW – (VB+VD+VE+VF) 
Ventilation rate QPC L/h/BW0.75 15 Brown et al. (1997) 
Cardiac output QCC L/h/BW0.75 15 Brown et al. (1997) 
Regional blood flow     
to skind QE L/h 1.7×10-2 QE = QEC × (Aexp/SURFA) 
to fat QF L/h 16.4 QF = QFC × QC 
to other tissues QO L/h 311.0 QO = QC – (QE+QF) 
Metabolic clearance parameters     
ratio of Vmax:KM Vmax/KM L/h 698 Willems et al. (2001) 
blood flow to liver QL L/h 75.3 QL = QLC × QC 
Partition coefficients     
blood:air Pb:a - 27.1 estimated 
stratum corneum:viable epidermis Psc:ve - 12.7 estimated 
VE:blood Pve:b - 2.8 McCarley and Bunge (2001) 
fat:blood Pf:b - 40.4 estimated 
other tissue:blood Po:b - 4.2 estimated 
Skin permeation parameters     
area of exposure Aexp cm2 20 Dimensions of the tape strip 
total body surface areae SURFA cm2 19238 (BW0.45) × (HT0.725) × 71.84 
permeability coefficient for  
stratum corneum Kps cm/h 5.2×10-4 estimated 
permeability coefficient for  
viable epidermis Kpv cm/h 2.0 estimated 
 
a Davies and Morris (1993) 
b The volume of the viable epidermis is calculated as the volume of the exposed skin minus the 
volume of the stratum corneum under the exposed area.  The fraction of body weight in skin (VEC) 
is from Brown et al. (1997) 
c The fraction of body weight in fat = ln BMI – 126.2 (Mills 2005). 
d The fractions of cardiac output to skin (QEC) and to liver (QLC) were obtained from Brown et al. 
(1997). 
e Total body surface area (Haycock et al. 1978). 
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4.3.4 Model parameters 
    All physiological parameters (cardiac output, ventilation rate, blood flow rate to the tissues, and 
tissue volumes) for humans were obtained from the literature (Table 9) (Brown et al. 1997).  Tissue 
partition coefficients were predicted from the octanol-water partition coefficients and regression 
models for different tissues (Abraham et al. 1985; Fiserova-Bergerova et al. 1984; Hansch et al. 
1995; Willems et al. 2001).  The maximum rate of naphthalene metabolism (Vmax) and Michaelis-
Menten constant (KM) have been estimated for rats and mice (Willems et al. 2001).  In our study, the 
rate of metabolism was assumed to follow first-order kinetics, given the relatively low naphthalene 
concentrations measured in post-exposure breath samples (Egeghy et al. 2003).   
 
4.3.5 Parameter estimation 
    Based upon preliminary sensitivity analyses, the blood:air partition coefficient (Pb:a) was most 
sensitive for predicting breath concentrations.  The Pb:a value of 571 for naphthalene reported by 
Willems et al. (2001) is unusually large.  For comparison, the Pb:a for some aromatic and aliphatic 
components of JP-8 are 8.8 for benzene (Thrall et al. 2002), 13.9 for toluene (Thrall et al. 2002), 6.9 
for decane (Smith et al. 2005), and 30.3 for dodecane (Smith et al. 2005).  Similarly, the fat:blood 
partition coefficient (Pf:a) was reported high (160.4) by Willems et al. (2001).  The reported Pf:a for 
benzene is 55 (Travis et al. 1990) and 25 for decane (Perleberg et al. 2004).  Field exposure data for 
Air Force personnel with only inhalation exposure (i.e., no dermal exposure) to naphthalene were 
used for optimization of Pb:a.  The optimized value of Pb:a was then kept constant, and the parameters 
Kuptake, Kpv, Psc:ve, Pf:a, and other tissue:blood partition coefficient (Po:b) were adjusted to fit the blood 
time course data for each volunteer in the laboratory study.  Initial values of all parameters were 
obtained from the literature (Guy and Potts 1992; McCarley and Bunge 2001; Qiao et al. 2000; 
Willems et al. 2001; Williams and Riviere 1995).  The Nelder-Mead algorithm was used to optimize 
parameters, with tolerance set at 1×10-5 (Xcellon 2004).  Relatively large ranges were allowed in the 
optimization step because little is known about them for naphthalene for humans under in vivo 
conditions. 
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4.3.6 Model validation 
    A subset of the Air Force data was set aside for validation of the optimized model.  This dataset 
included personnel who had both dermal and inhalation exposure to JP-8.  The concentrations of 
naphthalene in the air and dermal samples and the duration of exposure were used as input terms for 
the model.  Predicted end-exhaled breath concentrations were compared to measured levels of end-
exhaled breaths.   
    For the medium- and high-exposure groups, end-exhaled breath samples were collected 
immediately at the end of the work and, sometime later, at a central testing site (CTS).  Three US Air 
Force personnel were selected from the medium- and high-exposure groups, combined, who 
represented the 10th, 50th, and 90th percentiles based on the end-exhaled breath measurements.  The 
medium- and high-exposure groups included individuals who came in regular contact with jet fuel.  In 
addition, the high-exposure group consisted of fuel-cell maintenance workers who entered fuel tanks 
during their work.  Therefore, the concentration of naphthalene in the air was much higher in the 
immediate work environment for these two exposure groups compared to the low-exposure group, 
which had no direct contact with JP-8 and, therefore, represented background exposures to 
naphthalene.  The air concentration of naphthalene was reported for the duration of the sampling 
period, which included travel time to the CTS (approximately 30 min).  Thus, the air concentration at 
the work site was estimated as: 
 
work
travelesttotalPBZ
est t
t2INHALtC
1INHAL ∆
∆×−∆×=    (26) 
 
where INHAL1est is the concentration of naphthalene in the breathing zone during the work shift of 
∆twork h, CPBZ is the air concentration measured during the full sampling period of ∆ttotal h, INHAL2est is 
the background air concentration of naphthalene estimated for the low-exposed group, and ∆ttravel is 
the time required to travel from the workplace to the CTS. 
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4.3.7 Sensitivity analysis 
    Sensitivity analyses were performed to evaluate the relative importance of model parameters on 
the concentrations of naphthalene in end-exhaled breath.  Sensitivity coefficients were calculated 
using equation 27 (Evans and Andersen 2000).   
 
Sensitivity Coefficient
p
p
m
m
∆×
∆=      (27) 
 
where m is the response variable (i.e., concentration of naphthalene in end-exhaled breath), ∆m is 
the change in the response variable, p is the value of the parameter of interest (e.g., blood:air 
partition coefficient), and ∆p is the change in the parameter value.  Each parameter was changed 1% 
(i.e., ∆p ÷ p = 0.01). 
 
4.4 Results 
4.4.1 Inhalation exposure toxicokinetics 
    The PBTK model was optimized for inhalation exposure using data from 76 Air Force personnel 
(19 females and 57 males) who did not have dermal contact with jet fuel. Only Pb:a was adjusted to fit 
the end-exhaled breath concentrations of naphthalene in this low-exposure group.  The median 
height and weight of the personnel were 175 cm and 76 kg, respectively.  In the optimization 
procedure, the median air concentration of naphthalene was 2.0 µg/m3 (range: 0.7 - 482 µg/m3) and 
was held constant for the duration of exposure (median duration = 235 min).  For each US Air Force 
subject, the pre-exposure concentration of naphthalene in the end-exhaled breath was subtracted 
from the post-exposure measurements.  The median end-exhaled breath level of naphthalene was 
0.2 µg/m3 (range: 0 - 12.4 µg/m3).  The optimized value of Pb:a was 27.1. 
 
4.4.2 Dermal exposure toxicokinetics 
    The average height and weight of the subjects to which JP-8 was dermally administered was 174 
cm and 61 kg, respectively (BMI = 21 kg/m2).  Time-course plots showed considerable variability 
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among the study volunteers (Figure 14).  The mean and standard deviation (SD) of the peak 
concentration of naphthalene in blood was 0.18 ± 0.22 ng/ml and occurred at 62 ± 16 min.  The time 
course for subject No. 1 was very different from that of the other volunteers.  The peak concentration 
for this volunteer was 0.80 ng/ml and occurred at 37 min.  Model predictions of the blood 
concentration of naphthalene are also shown for each volunteer (Figure 14) using optimized 
parameter values.  The skin parameters (Kuptake, Kpv, and Psc:ve) and the partition coefficients Pf:b and 
Po:b were adjusted to fit the blood time course data for dermal exposures only.  The rate of input from 
dermal exposure is equivalent to the product of the permeability coefficient for the SC (Kps), the 
exposed surface area (Aexp), and the concentration of the naphthalene in JP-8 (CJP-8) (McCarley and 
Bunge 2001; McDougal and Boeniger 2002): 
 
rate of input = uptakeK  × DERMDOSE = Kps × Aexp × CJP-8   (28) 
 
Equation 28 can be rearranged to solve for the stratum corneum permeability coefficient Kps as 
follows: 
 
Kps = 
8JPexp
uptake
CA
DERMDOSEK
−×
×
      (29) 
 
The optimized value of Kuptake is 0.027 ± 0.053 h-1 (mean ± SD), and for Kps it is 5.2×10-5 ± 5.0×10-5 
cm/h (mean ± SD) (Table 10).  The effective permeability coefficient (Keff) for the epidermis is 5.2×10-5 
cm/h. 
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Table 10. Optimized values of the skin parameters Kuptake, Kpv, Psc:ve, Pf:b, and Po:b.  Kps was 
calculated using equation 29.  The parameters were optimized for each of the 10 
study volunteers. 
 
Volunteer Kuptake×10-3 (h-1) Kps×10-5 (cm/h) Kpv (cm/h) Psc:ve Pf:b Po:b 
1 176.8 17.4 0.0058 1.0 4.4 0.6 
2 3.4 0.8 9.1 4.8 1.3 2.0 
3 7.8 4.6 0.0059 4.3 75.0 6.2 
4 16.8 2.5 0.010 3.8 12.0 2.5 
5 7.3 5.1 0.020 5.9 3.9 2.0 
6 17.2 8.8 0.024 14.7 10.0 5.9 
7 10.2 5.6 0.00092 0.5 49.8 3.0 
8 20.0 4.4 0.26 78.5 61.6 17.3 
9 7.5 1.3 1.3 13.7 6.1 1.3 
10 3.1 1.1 9.1 0.2 180 1.1 
mean 27.0 5.2 2.0 12.7 40.4 4.2 
SD 53.0 5.0 3.8 23.7 56.1 5.0 
 
SD, standard deviation; 
Kps, the permeability coefficient for the stratum corneum; 
Kpv, the permeability coefficient for the viable epidermis; 
Kuptake, the rate constant for uptake into the stratum corneum; 
Psc:ve, the stratum corneum:viable epidermis partition coefficient; 
Pf:b, the fat:blood partion coefficient; 
Po:b, the other tissue:blood partition coefficient; 
DERMDOSE, dose to the skin; 
Aexp, exposed surface area; 
CJP-8, JP-8 concentration in the tape-strips. 
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Figure 13. Plots comparing the PBTK model simulations to experimentally measured 
naphthalene concentrations in blood from 10 study volunteers who were dermally 
exposed to JP-8 on the volar forearm. 
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4.4.3 Predictions of end-exhaled breath concentrations 
    Model predictions of the end-exhaled breath concentration of naphthalene were compared to field 
measurements among three Air Force personnel who represented the 10th, 50th, and 90th percentiles 
based on the end-exhaled breath concentrations.  These three US Air Force personnel were in the 
high-exposure group; thus, they spent time in a fuel tank during their work shift.  The input 
parameters and values for each US Air Force personnel are reported in Table 11.  The PBTK model 
consistently over-predicted the end-exhaled breath concentrations at the end of work for all three US 
Air Force personnel (Figure 14).  This could be attributed to the use of supplied-air respirators.  
Therefore, the air concentration of naphthalene during work (i.e., INHAL1est) was adjusted (i.e., 
INHAL1adj) to better estimate the true inhalation exposure (Figure 14).  The values of INHAL1adj are 
reported in Table 12. 
 
 
Table 11. Input parameters and values for prediction of end-exhaled breath concentrations of 
naphthalene in US Air Force personnel who represented the 10th, 50th, and 90th 
percentiles based on end-exhaled breath measurements. 
 
Variable 10th percentile 50th percentile 90th percentile 
height (cm) 175 188 168 
body weight (kg) 81 109 73 
INHAL1est (µg/m3) 499 322 3640 
INHAL2est (µg/m3) 2.0 2.0 2.0 
DERMDOSE (µg/cm2) 3.9×10-5 5.5×10-4 9.2×10-3 
Duration of exposure (min) 224 322 260 
 
INHAL1est, the estimated air concentration of naphthalene during work; 
INHAL2est, the background air concentration of naphthalene; 
DERMDOSE, dose to the skin. 
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Figure 14. Model simulations and end-exhaled breath concentrations for the US Air Force 
personnel who were exposed to JP-8 via inhalation and dermal routes.  Breath 
samples were collected immediately at the end of the work shift and at a central 
testing site (CTS).  Shown are the measured and predicted values for three US Air 
Force personnel who represented the 10th, 50th, and 90th percentiles of measured 
end-exhaled breath concentrations.  Simulations are also shown after adjusting the 
air concentration of naphthalene during work to better estimate the true inhalation 
exposure (adj model). 
 
 75
4.4.4 Sensitivity analysis 
    Normalized sensitivity coefficients (mean) were calculated separately for exposure and 
physiological parameters in the medium- and high-exposure groups.  The response variable in both 
sets of calculations was the concentration of naphthalene in the end-exhaled breath.  For exposure 
variables, the resulting sensitivity coefficients were positive (Figure 15).  The end-exhaled breath 
concentrations were most sensitive to the estimated air concentration of naphthalene during work 
(INHAL1est).  The sensitivity coefficient for INHAL1est was 1.0 for both the medium- and high-exposure 
groups.  End-exhaled breath concentrations were not sensitive to the variables DERMDOSE and 
Aexp.  In the PBTK model, the end-exhaled breath concentration of naphthalene was most sensitive to 
cardiac output (-0.7), ventilation rate (1.0), and the blood:air partition coefficient (-0.9) (Figure 16).  
The sensitivity coefficients for other parameters were less than |0.2|. 
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Figure 15. Normalized sensitivity coefficients for the end-exhaled breath concentrations in the 
medium- and high-exposure groups.  The parameters INHAL1est and INHAL2est are 
the naphthalene air concentrations (µg/m3) during work and during travel to the 
central testing site, respectively.  DERMDOSE is the mass (µg) of naphthalene in the 
tape strips and Aexp is the area of the exposed site (cm2).  Parameters were adjusted 
at the 1% level. 
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Figure 16. Normalized sensitivity coefficients for the end-exhaled breath concentrations in the 
medium- and high-exposure groups.  Physiological and biochemical parameters were 
adjusted at the 1% level.  Explanation of abbreviations can be found in Table 9. 
 
 
 
4.4.5 Comparison of dermal and inhalation exposure routes 
    Simulations were conducted for three US Air Force personnel to compare the contribution of 
dermal exposure to the end-exhaled breath concentrations relative to inhalation exposure (Table 12).  
These three individuals were all fuel-cell maintenance workers.  The area under the end-exhaled 
breath concentration-time curve (AUCex) was calculated for dermal exposures using the following 
equation: 
 
dt)t(CAUC
1t
0t
exex ∫=       (30) 
 
where Cex is the concentration of naphthalene in the end-exhaled breath and t1 is the time at the end 
of the exposure.  The values of AUCex for dermal exposures were 0.8, 18.6, and 310 µg·min/m3 for 
the 10th, 50th, and 90th percentiles, respectively.  Dermal exposures were set to zero and the 
naphthalene air concentration was adjusted to obtain the same value of AUCex.  The predicted air 
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concentrations (INHAL1pred) were 0.05 µg/m3, 0.71 µg/m3, and 15.7 µg/m3, respectively.   These 
values are 0.3%, 1.7%, and 6.9% of the air concentrations of naphthalene for the individuals whose 
breath measurements represented the 10th, 50th, and 90th percentiles, respectively. 
 
 
Table 12. Estimated contribution of dermal exposure to the end-exhaled breath concentrations 
of naphthalene relative to inhalation exposure.  This analysis was based on three US 
Air Force personnel whose end-exhaled breath concentrations represented the 10th, 
50th, and 90th percentiles.  The ratio of INHAL1pred to INHAL1adj is a measure of the 
relative percent contribution of dermal exposure to the internal dose.   
 
Percentile Breath (µg/m3) 
AUCex 
(µg·min/m3) 
INHAL1adj 
(µg/m3) 
INHAL1pred 
(µg/m3) Ratio (%) 
10% 1.7 0.8 16.4 5.0×10-2 0.3 
50% 4.7 18.6 40.8 0.7 1.7 
90% 29.4 310 227 15.7 6.9 
 
AUCex, area under the breath concentration-time plot for dermal exposures only; 
INHAL1adj is the adjusted value of INHAL1est, and better represented the inhalation 
exposures of fuel-cell maintenance personnel who wore respirators during work inside fuel 
tanks; 
INHAL1pred was determined by varying the air concentration of naphthalene to obtain the 
same value of AUCex. 
 
 
 
 
4.5 Discussion 
    The PBTK model was developed to predict end-exhaled breath concentrations of naphthalene 
following dermal and inhalation exposure to JP-8.  Our model consisted of five compartments 
representing the stratum corneum, viable epidermis, blood, fat, and other tissues, and contains fewer 
parameters than previously published physiologically based compartmental models of naphthalene 
(Quick and Shuler 1999; Willems et al. 2001).  The fat was considered separate from the other 
tissues because the time constant for fat (13.5 h) was larger than the time constant for other tissues 
(0.7 h).  However, the other tissue compartment was included in the model because the skin 
compartment consisted of the skin directly under the exposed area.  The remaining skin was included 
in the other tissue compartment.   
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    Adjustments had to be made to the blood:air and fat:blood partition coefficients for the PBTK model 
predictions to fit the experimental and occupational exposure data.  For many chemicals, the partition 
coefficients are not known.  In such cases, quantitative structure-activity relationship (QSAR) models 
may be used to predict the necessary partition coefficients; however, the predictions are limited to 
chemicals with physicochemical properties that lie within the calibration dataset (Beliveau et al. 2003).  
In our study, we calibrated the values of Pb:a and Pf:b, which were predicted by Willems et al. (2001) 
using QSAR models, against human exposure data.  We estimated a Pb:a value of 27.1 for 
naphthalene, which is more realistic than the value of 571 reported by Willems et al. (2001).  Also, we 
estimated a Pf:b value of 40.4 for naphthalene, which is more plausible given that the Pf:b for benzene 
is 55 and 25 for decane.  Pb:a and Pf:b were identified as sensitive parameters in the model, and 
optimization of these parameter values was necessary for accurate prediction of the kinetic behavior 
of naphthalene. 
    The optimized PBTK model was used to predict end-exhaled breath measurements collected in the 
workplace from US Air Force personnel exposed via inhalation and dermal contact.  The three US Air 
Force personnel who were selected based on their end-exhaled breath concentration representing 
the 10th, 50th, and 90th percentiles were all in the high-exposure group.  We observed that the median 
contribution of dermal exposure to the internal dose of naphthalene was relatively small (1.7%).  
However, in the US Air Force personnel who represented the 90th percentile, the relative contribution 
of dermal exposure to the internal dose was 6.9%.  The high-exposure group consisted of fuel-cell 
maintenance workers.  These workers wore personal protective equipment, which included forced 
supply-air respirators, while working in the fuel tank.  The use of dermal protective equipment can 
further decrease the internal dose of naphthalene in the fuel-cell maintenance workers.   
    The PBTK model was used to calculate the permeability coefficient (Kp) for naphthalene in humans 
in vivo.  Previously, the Kp had been calculated using Fick’s law of diffusion.  A Kp value of 5.1×10-4 
cm/h was estimated in vitro (McDougal et al. 2000).  This in vitro Kp value was compared to a Kp 
value that was estimated by calculating the flux value for aromatic and aliphatic components of JP-8 
in humans from the slope of the linear portion of the cumulative mass of chemical in blood per cm2 vs. 
time curve (Kim et al. 2006).  We calculated an apparent Kp of 5.3×10-5 cm/h, which is approximately 
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an order of magnitude different from the rat Kp.  This Kp calculation was revised using a DTK model 
and equation 29.  A larger Kp value was estimated (1.8×10-3 cm/h), which was more similar to the Kp 
estimated in vitro by McDougal et al. (McDougal et al. 2000).  The limitation of using a data based 
compartmental model is that the parameter values are not constrained by the actual anatomy and 
physiology of the human body, and the biochemistry of naphthalene in vivo.  We incorporated such 
constraints into our PBTK model and revised our calculation of Kp for naphthalene.  We estimated a 
Kps value of 5.2×10-5 cm/h and a Kpv value of 2.0 cm/h.  The value of Keff, which is the overall 
permeability coefficient for chemicals crossing the skin (McCarley and Bunge 2001), is 5.2×10-5 cm/h.  
The estimated value of Keff is the same as Kps. 
    Keff is about an order of magnitude smaller than the Kp reported by McDougal et al. (2000).  A ten-
fold difference in the value of the permeability coefficient was not unexpected because rat skin is 
more permeable than human skin (McDougal et al. 2000).  Molecular diffusion is the dominant 
mechanism that governs the permeation of naphthalene across the skin.  For diffusion, the flux (and 
Kp) is inversely proportional to the thickness of the diffusion distance, as stated by Fick’s first law of 
diffusion.  Therefore, doubling the thickness of the skin will result in halving the Kp.  McDougal et al. 
(2000) estimated Kp across rat skin of thickness 560 µm.  The human skin thickness ranges from 500 
µm to 4000 µm; therefore, the human Kp value is expected to be between 6.4×10-5 cm/h and 5.7×10-4 
cm/h.  Our estimate of the effective permeability coefficient for naphthalene represents the lower limit 
of this range.  However, we observed a considerable amount of variation in the values of Keff.  Further 
study of the sources of the observed variation in permeability coefficient values is needed. 
    The approach taken in this study represents a useful technique for modeling and assessing the 
contribution of dermal and inhalation exposures to the systemic levels of naphthalene.  This PBTK 
model has reduced the uncertainty in modeling JP-8 exposures because fewer parameters were 
required to predict the time-course of naphthalene.  However, our model has also identified some 
data gaps.  First, inhalation exposures should be measured over shorter time intervals.  Sensitivity 
analysis of exposure parameters for the medium- and high-exposure groups demonstrated that end-
exhaled breath levels of naphthalene were most sensitive to the air concentration of naphthalene 
during work.  In our study, we used time-weighted average concentrations (over approximately 4 h), 
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which did not capture exposures to high levels of naphthalene from local sources.  Therefore, shorter 
time-resolved data may be used to better explain the transient nature of inhalation exposures to JP-8.  
Second, the blood:air partition coefficient for naphthalene should be determined experimentally, for 
example, using the vial-equilibration technique (Sato and Nakajima 1979).  The sensitivity analysis 
showed that the concentration of naphthalene in the end-exhaled breath was highly sensitive to Pb:a.  
Therefore, accurate measurement of the Pb:a value will reduce some of the uncertainty in the model.  
The Pb:a values for other JP-8 components should also be determined experimentally since human 
Pb:a values are unavailable for many of these aromatic and aliphatic hydrocarbons.  Finally, 
occupational and environmental exposure studies of other components of JP-8 are needed to gain a 
more complete picture of JP-8 exposures.  Currently, occupational exposure studies have focused on 
single chemical components of JP-8.  The results of multi-chemical exposure assessment studies 
may be compared to results from single-chemical studies, and add to our understanding of the 
absorption, distribution, metabolism, and elimination of complex chemical mixtures. 
    In conclusion, the PBTK model was used to quantify the contribution of dermal exposures to the 
systemic levels of naphthalene.  We estimated a permeability coefficient that was 10-fold lower than 
estimates made in vitro.  However, we observed a wide range of permeability coefficient values and, 
thus, recommend further study of the sources of inter- and intra-individual variation.  Overall, we have 
used a combination of exposure assessment, biological monitoring, and toxicokinetic modeling tools 
to integrate external exposure and biomarker data into a single description of the toxicokinetic 
behavior of naphthalene.  We constructed a PBTK model of dermal and inhalation exposure to jet fuel 
that required estimation of fewer parameters than previously published PBTK models of naphthalene.   
This PBTK model, which included two major exposure routes relevant to occupational and 
environmental exposure scenarios, may be used for integrating animal and human observational 
studies into an improved understanding of human health risks. 
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CHAPTER 5 
 
DISCUSSION AND CONCLUSIONS 
 
 
 
 
    The series of papers in this dissertation have presented three distinct contributions to the scientific 
literature.  The first paper presented the overall study design and the results from a human volunteer 
study of dermal exposure to JP-8.  The second paper presented four dermatotoxicokinetic models of 
aromatic and aliphatic hydrocarbons.  Each of these models was used to predict the time course of 
naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, decane, undecane, and dodecane.  
Dermal exposure measurements from US Air Force personnel and Monte Carlo analyses were 
conducted to examine the distribution of the cumulative internal dose for the six JP-8 components.  In 
the third paper, the structure of the DTK model was used to construct a PBTK model that integrated 
both the dermal and inhalation routes of exposure.  This PBTK model was used to predict 
occupational exposure to JP-8 in USAF personnel, and to quantify the contribution of dermal 
exposure to the internal dose of naphthalene.  The most significant results that have furthered our 
understanding of how chemicals are absorbed into the skin and taken up into the systemic circulation 
are discussed in this chapter. 
 
5.1 Absorption and penetration of JP-8 across skin 
    In chapter 2, the controlled dermal exposure study of JP-8 was described in detail.  The findings 
from this human volunteer study have made several contributions to our knowledge of dermal 
exposures to complex chemical mixtures.  Chemicals deposited on the skin can evaporate from the 
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surface, be absorbed into deeper layers of the skin, be metabolized, or penetrate the skin for 
distribution to other tissues.  Most pharmacokinetic and toxicokinetic studies of topically applied 
chemicals are performed in vitro.  However, these models are not necessarily predictive of the 
disposition of chemicals in humans.  Extrapolation of results from animal studies to humans is 
affected by a considerable amount of uncertainty.  The human volunteer study had several design 
characteristics that were similar to in vitro studies: (1) JP-8 was applied to the surface of the skin, (2) 
the amount that penetrated the skin was determined at specific time points, and (3) the mass of 
chemical absorbed by the skin was quantified.  This study provided an opportunity to directly compare 
the absorption and penetration of JP-8 components between animals in vitro and humans in vivo.   
    The patterns of dermal absorption and penetration of six JP-8 components were consistent 
between in vitro and in vivo studies.  First, the tape-strip data showed evidence of absorption of 
naphthalene, 1-methyl naphthalene, 2-methyl naphthalene, decane, undecane, and dodecane.  
Second, aromatic compounds had apparent Kp values that were an order of magnitude larger than 
aliphatic compounds.  Third, naphthalene had the largest apparent Kp.  The rank order of the 
apparent Kp values were similar to results from McDougal et al. (2000).  A significant difference was 
that the human permeability coefficient was 10-fold lower than estimates made in vitro; however, a 
wide range of Kp values was estimated.  Therefore, further study of the sources of inter- and intra-
individual variation in human Kp values is recommended.  Overall, what can be concluded from these 
comparisons is that in vitro studies may be used to predict dermal absorption and penetration of JP-8 
components in humans.  However, these in vitro studies are limited to initial assessments of the 
absorption and penetration of chemicals across human skin because they do not capture the inter-
individual variability observed in human populations. 
 
5.2 Dermatotoxicokinetic model of the skin 
    In chapter 3, four dermatotoxicokinetic models of human exposure to JP-8 were presented.  Two 
major contributions to the scientific literature were made: (1) toxicokinetic parameters were obtained 
for dermal exposures in humans, and (2) a mathematical model of the skin was developed that could 
be used to facilitate a modeling strategy for dermal exposures to complex chemical mixtures.  The 
 83
best description of the skin was a two-compartment model where the first compartment represented 
the stratum corneum and the second compartment represented the viable epidermis.  This structure 
represented a more plausible description of the skin since the stratum corneum and the viable 
epidermis have very different anatomical and biochemical characteristics. 
    The optimal DTK model was used to simulate the time-course of naphthalene and other 
components of JP-8 using information collected from an occupational exposure assessment study 
(Chao et al. 2005).  The predicted internal dose was distinctly different among the low-, medium-, and 
high-exposure groups.  Therefore, these simulations supported the use of the tape-strip technique to 
measure dermal exposures to complex chemical mixtures in exposure assessment studies. 
 
5.3 PBTK model of occupational exposure to JP-8 
    Building upon the structure of the optimal DTK model, a PBTK model was constructed and used to 
quantify the relationship between environmental exposures and the internal dose of naphthalene 
(Chapter 4).  This model represented the first attempt at incorporating both the dermal and inhalation 
routes of exposure into a single description of the kinetic behavior of naphthalene in humans.  The 
PBTK model consisted of 5 compartments representing the stratum corneum, viable epidermis, 
blood, fat, and other tissues.  Model parameters were calibrated against data from an occupational 
exposure and a laboratory study.  The optimized values of parameters were blood:air partition 
coefficient = 27.1, fat:blood partition coefficient = 40.4, permeability coefficient for the stratum 
corneum = 5.2×10-5 cm/h, stratum corneum:viable epidermis partition coefficient = 12.7, and 
permeability coefficient for the viable epidermis = 2.0 cm/h.  Adjustments to the blood:air partition and 
fat:blood partition coefficients had to be made to fit the time course data for naphthalene in blood.  
The adjusted values of the partition coefficients were more realistic than the literature values (Willems 
et al. 2001) when compared to the partition coefficients for similar compounds. 
    The major scientific contribution of the PBTK model was that it had been constructed using data 
from (1) an observational study of occupational exposures and (2) a human volunteer study where 
exposures were controlled.  The optimized PBTK model was used to reveal some of the errors 
related to environmental sampling.  This PBTK modeling approach represented a shift from model 
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development using laboratory animals towards model application in humans, as demonstrated by the 
simulations of occupational exposures to JP-8.  The simulations showed that the median contribution 
of dermal exposure to the internal dose of naphthalene was 1.7% (10th percentile = 0.3% and 90th 
percentile = 6.9 %).  These findings suggest that implementation of dermal exposure controls that 
target the dermal route will further decrease the internal dose of naphthalene in fuel-cell maintenance 
workers.  Overall, the third paper presented a novel application of PBTK models.  Given the use of 
personal protective equipment, prior statistical evaluations had found it difficult to determine the 
relative contributions of dermal and inhalation exposures to the systemic levels of JP-8 components.  
In this study, PBTK modeling human exposures to JP-8 using diverse data sets revealed the 
quantitative relationship between external exposure measurements and the internal dose of 
naphthalene.  The approach taken in this study has, therefore, added to the current understanding of 
the toxicokinetic behavior of naphthalene, and has pointed to a novel way of assessing human 
exposures to chemical mixtures. 
 
5.4 Summary of scientific contributions 
    This investigation has provided three significant scientific contributions to the study of dermal 
exposures to complex chemical mixtures.  The controlled dermal exposure study was the first 
published work that gave some insight into the dermal absorption and penetration of JP-8 
components in humans.  Further, this investigation provided an opportunity to compare in vivo 
estimates of the permeability coefficient to those made in vitro using rat skin and Franz diffusion cells.  
The second significant addition was the development of a dermatotoxicokinetic model for JP-8 
exposures in humans.  This model represented the first attempt at estimating rate constants that were 
directly relevant for humans.  The model was used to demonstrate the differences in internal dose for 
dermal exposures in the low-, medium-, and high-exposure categories.  The final scientific 
contribution was the development of a human PBTK model that included both the dermal and 
inhalation routes of exposure.  This PBTK model was constructed using a combination of exposure 
assessment, biological monitoring, and toxicokinetic modeling tools.  The uniqueness of this PBTK 
model was that it was calibrated and validated exclusively with human exposure and biomarker data.  
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Therefore, the optimal model could be used to predict occupational exposures without the uncertainty 
associated with extrapolating from animal studies.  Future studies may adopt this modeling strategy 
for assessing the risks associated with exposures to complex chemical mixtures in human 
populations. 
 
5.5 Limitations and suggestions for future research 
    There were several limitations to this study.  First, there was a paucity of exposure data that could 
be used to explain the exposure-internal dose relationship for work-related activities.  The 
occupational exposure data consisted of time-weighted average inhalation exposure data and sparse 
end-exhaled breath measurements.  Since the half-life of naphthalene is approximately 22 min 
(Egeghy et al. 2003), the time-weighted average exposure data (e.g., over a 4 h work-shift) make it 
difficult to quantify the exposure-internal dose relationships for complex exposure patterns.  Second, 
exposure measurements for specific tasks were not available.  Therefore, it was difficult to 
reconstruct the exposure scenario that corresponded to the end-exhaled breath measurements.  
Detailed information about the times at which exposures occurred and the exposure levels during 
those time periods are necessary for improving the inputs to the PBTK model.  Third, partition 
coefficients were not available for naphthalene but had to be estimated using the time course data for 
naphthalene.  However, the time course of naphthalene in blood and in breath is a composite 
behavior governed by fundamental physiological and biochemical processes.  Thus, partition 
coefficients should be determined separately using (for example) a vial-equilibration technique.  
    This investigation has generated new ideas for future research that address some of the 
aforementioned limitations.  In particular, the PBTK model has provided insight into the expansion of 
the current model, specifically in making it more useful for human exposure and risk assessment.  In 
order to improve understanding of the kinetic behavior of compounds that are sequestered in deeper 
layers of the skin, experiments are needed to measure chemicals that evaporate from the surface of 
the skin after exposure has stopped.  This experiment will answer questions about the possibility of 
reverse-diffusion (i.e., from deeper skin layers to the surface rather than toward the systemic 
circulation).  Studies that measure the rates of metabolism in the skin are also needed to understand 
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the effect of metabolism on the disposition of chemicals in the skin and in the systemic circulation.  In 
both data-based and physiologically-based compartmental models, the diffusion of chemicals across 
the stratum corneum was modeled as a one-directional diffusive process.  Therefore, compartmental 
models should be compared to membrane models of the skin to validate this assumption.  Further 
occupational exposure studies are needed to better understand dermal exposures to JP-8 during 
specific work tasks.    Measurements of the time-weighted average concentration of JP-8 components 
over the duration of a work-shift do not capture exposures to peak levels of naphthalene from local 
sources.  Shorter time-resolved data can be used to better explain the transient nature of inhalation 
exposures to JP-8, and to elucidate the effect of short-term JP-8 exposures on the toxicokinetic 
behavior of naphthalene.  Finally, future studies of JP-8 should measure not only one component but 
many JP-8 components to gain a more complete picture of JP-8 exposures.  The results of these 
studies may then be compared to results from single-chemical studies, and add to our understanding 
of the absorption, distribution, metabolism, and elimination of complex chemical mixtures.  Better 
understanding of the kinetic behavior of complex chemical mixtures can make plausible the findings 
from epidemiological investigations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 87
APPENDIX A: 
PROTOCOLS FOR THE CONTROLLED DERMAL EXPOSURE STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 88
A.  PROTOCOL FOR PREPARATION OF SAMPLING EQUIPMENT  
 
 
 
MATERIALS (for 1 subject): 
 
 
N.B.  For storage of urine, blood, and internal standards, use the 10 or 20 ml vials with crimp-top 
because this seals better. 
 
• Exposure chamber 
• 9.5 mm Thermogreen septa LB-2 (2) 
• 500 ul syringe with blunt end (2) 
• Latex gloves (1 box) 
• 50 ml Urine collections vials (16) 
• 10 ml Blood sampling tubes (8) 
• Crimper and De-crimper 
• 10 ml Headspace vials (8) 
• 20 ml Headspace vials (6) 
• PTFE crimp-top caps (14) 
• 50 ml conical vials (6) 
• 15 ml conical vials (8) 
• 20 ml Scintillation vials (15) 
• 20 ml Pipette 
• Automated pipetter 
• 75 ml Glass bulb (12) 
• Passive sampling tubes (20) 
• JP-8 jet fuel 
• 50 µl pipette with tips 
• Internal standard (Naphthalene d8 + Dodecane d26) 
• Acetone (bottle and dispenser) 
• DI water 
• 4 beakers 
• Labels 
• Clipboard 
• Pre-printed tables for each subject 
 
 
SAMPLE LABELING 
 
S AaBbCc 
 
where S = sample type, Aa = Subject ID; Bb = Visit number; Cc = Sample number.   
 
The sample type identifiers are U = urine, D = skin, B = blood, R = breath, C = chamber, P = personal 
breathing zone, T = boat, J = 0.5 ml of JP8 
 
Time (24:00) and Date (year/month/day) 
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PREPARATION OF INTERNAL STANDARDS: 
 
1. For urine and blood internal standards, do the following: 
a. Dissolve 0.1 g naphthalene d8 in 20 ml of methanol.  This is the stock solution.  Label 
it as urine/blood naphthalene d8 stock, record concentration, and date. 
b. Dissolve 0.1 g n-dodecane d26 in 20 ml of methanol.  This is the stock solution.  Label 
it as urine/blood n-dodecane d8 stock, record concentration, and date. 
c. Aliquot 1 ml of each of the stock solutions into a 25 ml volumetric flask.  Fill to 25 ml 
with methanol.  Label as 1st dilution, record concentration, and date.  Store the 
remaining solution in 20 ml HS vials with crimp-top. 
d. Aliquot 0.625 ml of the 1st dilution into a 25 ml volumetric flask.  Fill to 25 ml with 
methanol.  This is the internal standard.   
e. Transfer the internal standard to a 20 ml head-space vial with crimp-top.  Label it as 
urine/blood internal standard, record concentration, and date. 
f. Store the stock and internal standard at -80 °C. 
 
2. For dermal internal standard 
a. Dissolve 0.1 g naphthalene d8 in 20 ml of acetone.  This is the stock solution.  Label it 
as dermal naphthalene d8 stock, record concentration, and date. 
b. Dissolve 0.1 g naphthalene d8 in 20 ml of acetone.  This is the stock solution.  Label it 
as dermal stock and date. Label it as dermal n-dodecane d26 stock, record 
concentration, and date. 
c. Aliquot 5 ml of the stock solution into a 25 ml volumetric flask.  Fill to 25 ml with 
acetone.  This is the internal standard.   
d. Transfer the internal standard to a 20 ml head-space vial with crimp-top.  Label it as 
dermal internal standard, record concentration, and date. 
e. Store the internal standard at -80 °C. 
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B.  PROTOCOL FOR SAMPLE COLLECTION (PRE-EXPOSURE) 
 
 
 
All equipment for collection of samples must be prepared in advance.  The following protocol is to be 
completed on the day before and prior to exposing the subject(s) in the chamber. 
 
 
DAY BEFORE EXPOSURE: 
 
1. Condition the passive sampling tubes in Dr. Rappaport’s laboratory, first at 250°C and second 
at 225°C.  Conditioned tubes are capped and stored at room temperature. 
 
2. Prepare the breath sampling bulbs by rinsing with deionized water and acetone.  Do not rinse 
the caps.  Air dry at room temperature. 
 
3. Make internal standards if necessary. 
 
4. Bake out the vials and caps for storing blood and urine in the oven in the 4th floor lab at 80 °C 
overnight. 
 
5. Print out the labels with subject ID, visit number, sample number, and date. 
 
6. Leave space in notebook for the following information: (1) date, start and stop times for 
exposure, and (2) tables for dermal, breath, blood, and urine samples.  Construct tables in the 
lab notebook with the following headings: subject ID, visit number, sample number, date, and 
time. 
 
7. Cut out 140 dermal tape strips 
 
 
DAY OF EXPOSURE: 
 
1. Cool down the blood and urine vials first thing in the morning inside the fume hood. 
 
2. Replace thermogreen septa 
 
3. Have air sampling tubes, 0.5 ml syringes, and dermal tape strips on the workbench near the 
exposure chamber. 
 
4. Have internal standard, and HS vials in the fume hood for dermal, urine and blood sample 
collection.   
 
5. Label sixty-two 20 ml scintillation vials and place 10 ml of acetone and 20 µl of internal 
standard (IS = naphthalene d8 and dodecane d26) in them.   
 
6. Place 0.5 ml of the JP-8 fuel into one of the 20 ml scintillation vials containing 9.5 ml acetone 
and 20 µl internal standard.  Label and store in -20°C. 
 
7. Set aside two 20 ml scintillation vial for the JP-8 residue from the position holders.  These vials 
should contain 9.5 ml of acetone and 20 µl of internal standard. 
 
8. Greet the volunteer and take him/her to the waiting area.  Store the volunteer’s personal 
belongings and lunch in the student office. 
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9. Brief the volunteer on the day’s events using the time chart.  Record the subject’s body weight, 
height, and fat content.  Ask if he/she has any questions. 
 
10. Have the volunteer provide a urine sample.  Record the time in the lab notebook and on the 
pre-labeled sample vial.  Transfer the urine sample to 2 pre-labeled 20 ml HS vials (urine is 
stored in duplicate).  Store in -20ºC refrigerator. 
 
11. Direct the volunteer to the exposure chamber and have him/her seated in a comfortable 
position. 
 
12. Explain how the breath sample is to be given.  Have the volunteer provide a breath sample.  
Record the time in the lab notebook and on the pre-labeled sample tube.   
 
13. Ask the nurse to draw a blood sample from the volunteer.  Record the time in the lab notebook 
and on the pre-labeled blood test tube.  Transfer the blood sample to pre-labeled 10 ml HS 
vials.  Store in -20ºC refrigerator.   
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C.  PROTOCOL FOR SAMPLE COLLECTION (EXPOSURE) 
 
 
 
The following steps are to be taken once pre-exposure samples (urine, breath, and blood) are 
collected and the volunteer is comfortably seated in the chair in preparation for the 30 minute 
exposure period. 
 
1. Place a passive air monitor on the volunteer’s lapel.  Record the time in the lab notebook and 
on the sampling device.0 
 
2. Insert the volunteer’s arm into the exposure chamber.  Seat the aluminum application chamber 
onto the volunteer’s arm.  Ensure the volunteer’s comfort.  Adjust the arms so that there is a 
tight seal on the forearm.  Ensure that the subject has circulation to the fingertips. 
 
3. Apply JP-8 to the volunteer’s forearm.  Record the time of the first application of JP-8 in the lab 
notebook.  Also make note of which site JP-8 was applied first.   
 
4. Place a Tenax sampling tube in opening end of the chamber.  Tenax tubes are changed every 
5 minutes.  Record the start/stop times for each. 
 
5. Collect breath samples at t = 5 min, 10 min, 15 min, 20 min, and 25 min.  Record the times that 
the breath samples are collected in the lab notebook and on the pre-labeled sample tubes.    
 
6. Collect blood samples half way through the 30 minute exposure (i.e. t = 15 min).  Record the 
time that the blood is drawn in the lab notebook and on the blood test tube.  Transfer the blood 
into pre-labeled 10 ml HS vials.  Store the blood in the -20ºC refrigerator. 
 
7. Immediately before the end of 30 minutes of exposure, collect breath and blood samples.  
Record the times that the breath and blood samples are collected in the lab notebook and on 
the pre-labeled sample tube and vial.  Transfer 3 ml of blood into a pre-labeled 10 ml HS vial; 
transfer the remaining blood into 15 ml conical tubes.  Store the blood in the -20ºC refrigerator. 
 
8. Remove the final Tenax tube from the chamber at the end of the 30 minutes of exposure. 
 
9. Extract the remaining JP-8 from the two sites of exposure and transfer into pre-labeled 20 ml 
scintillation vials that contain 20 ml of acetone and 20 µl of IS. 
 
10. Carefully raise the application chamber and remove the volunteer’s arm from the exposure 
chamber. 
 
11. Wash the aluminum chambers with 10 ml of acetone for each site and collect in a large beaker.  
Transfer the contents of the beaker to the 20 ml scintillation vials used to extract dermal 
samples; insert 20 µl IS to this vial.  Wash the exposure chamber with deionized water. 
 
12. Apply tape to the exposed sites and record the time.  Leave the tape on the skin for 2 min.   
 
13. Slowly remove the tape at 45º from both sites on the forearm and place in corresponding pre-
labeled 20 ml scintillation vials that contain 10 ml of acetone and 20 µl of IS.  Record the time 
that the tapes are removed.  Switch gloves and place new tape on both sites on the forearm.  
Record the time that the tapes are applied.  Leave tape on the skin for 2 min.   
 
14. Repeat step 12 until each site on the forearm has been tape stripped up to 30 times.  
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D.  PROTOCOL FOR SAMPLE COLLECTION (POST-EXPOSURE) 
 
The following steps are to be taken upon completion of tape stripping the skin. 
 
1. Collect breath sample.  Record the time that the breath sample is collected in the lab notebook 
and on the pre-labeled sample tube.    
 
2. Collect blood sample.  Record the time that the blood is drawn in the lab notebook and on the 
blood test tube.  Transfer the blood into pre-labeled 10 ml HS vials.  Store the blood in the -
20ºC refrigerator. 
 
3. Collect urine sample.  Record the time in the lab notebook and on the pre-labeled sample vial.  
Transfer the urine sample to 4 pre-labeled 20 ml HS vials.  Store the urine in the -20ºC 
refrigerator. 
 
4. Assist the volunteer into the student office.  Instruct the volunteer not to leave the student office 
except for snacks, beverages, lunch, or washroom breaks. 
 
5. Repeat steps 1-3 hourly until four more breath, blood, and urine samples are collected. 
 
6. At the end of the day, remove the passive air monitor from volunteer.  Record the time in the 
lab notebook and on the sampling device. 
 
7. Remove all other experimental objects from the volunteer (e.g. catheter). 
 
8. Place passive sampling tubes inside the breath sampling bulbs for overnight extraction.  
Immediately cap the passive sampling tubes in the morning and store at room temperature. 
 
9. Ensure that all blood, urine, breath, dermal, chamber air, personal breathing zone samples are 
correctly labeled and stored.   
 
10. Ensure that all forms (consent and personal data) are completed and signed. 
 
11. Set up an appointment for the 2nd exposure.  Inform the volunteer that they will be reminded 1 
week and 1 day prior to the next appointment. 
 
12. Give 10 urine containers in cooler with icepacks, and instruct the volunteer to collect urine at 
every void, labeling with time and data.  Have the subject come in the next morning with cooler 
and icepacks. 
 
13. Give reimbursement for their contribution to the study once all urine samples have been 
returned. 
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APPENDIX B: 
DERMATOTOXICOKINETIC MODEL PROGRAM 
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PROGRAM: dtk.csl 
! Developed for JP-8 skin exposure MODEL D 
! by David Kim 
! Department of Environmental Sciences and Engineering, School of Public Health 
! The University of North Carolina at Chapel Hill 
! Construction of this program began on Nov 29, 2005 
 
 
INITIAL      ! Beginning of pre-execution section 
 
CONSTANT    BW = 70    ! Body weight of individuals (kg) 
CONSTANT  AEXP = 20000   ! Surface area of exposure (cm^2) 
 VB = 72.447*(BW**1.007)   ! Volume of blood (ml) 
 
 
!-------******************************--------------! 
!-------     KINETIC CONSTANTS    -----------! 
!-------******************************--------------! 
 
constant k0N = 4.10E-04 
constant k1N = 1.9 
constant k2N = 35 
constant k3N = 43 
constant k4N = 0.04 
constant k5N = 1.4 
constant k6N = 0.1 
   
constant k0N1m = 7.80E-05 
constant k1N1m = 1 
constant k2N1m = 10 
constant k3N1m = 29 
constant k4N1m = 0.04 
constant k5N1m = 1.9 
constant k6N1m = 0.13 
   
constant k0N2m = 2.50E-04 
constant k1N2m = 1.2 
constant k2N2m = 30 
constant k3N2m = 42 
constant k4N2m = 0.04 
constant k5N2m = 0.8 
constant k6N2m = 0.11 
   
constant k0C10 = 6.90E-04 
constant k1C10 = 1.9 
constant k2C10 = 42 
constant k3C10 = 51 
constant k4C10 = 0.13 
constant k5C10 = 1.6 
constant k6C10 = 0.15 
   
constant k0C11 = 1.60E-04 
constant k1C11 = 1.9 
constant k2C11 = 59 
constant k3C11 = 62 
constant k4C11 = 0.09 
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constant k5C11 = 1.8 
constant k6C11 = 0.07 
 
constant k0C12 = 7.90E-05 
constant k1C12 = 1.9 
constant k2C12 = 48 
constant k3C12 = 55 
constant k4C12 = 0.1 
constant k5C12 = 2 
constant k6C12 = 0.07 
 
 
!-------DOSING 
 
CONSTANT CBinitN = 0  ! Initial amount in blood 
CONSTANT CBinitN1m = 0 
CONSTANT CBinitN2m = 0 
CONSTANT CBinitC10 = 0 
CONSTANT CBinitC11 = 0 
CONSTANT CBinitC12 = 0 
 
 
CONSTANT   CJP8N = 344   ! Concentration of JP8 component in first tape strip (ng/m2) 
CONSTANT   CJP8N1m = 304 
CONSTANT   CJP8N2m = 283 
CONSTANT   CJP8C10 = 237 
CONSTANT   CJP8C11 = 4033 
CONSTANT   CJP8C12 = 7277 
 
 
!-----CALCULATED PARAMETERS 
 
 MJP8N = CJP8N*AEXP/10000000   ! Mass applied (ug) 
 MJP8N1m = CJP8N*1.4*AEXP/10000000    
 MJP8N2m = CJP8N*1.3*AEXP/10000000    
 MJP8C10 = CJP8N*1.1*AEXP/10000000     
 MJP8C11 = CJP8N*18.7*AEXP/10000000     
 MJP8C12 = CJP8N*33.7*AEXP/10000000     
 
  ABinitN = VB*CBinitN/1000 
  ADinitN = ABinitN*k4N/k3N 
  APinitN = (k5N/k6N)*ABinitN 
   
  ABinitN1m = VB*CBinitN1m/1000 
  ADinitN1m = ABinitN1m*k4N1M/k3N1M 
  APinitN1M = (k5N1M/k6N1M)*ABinitN1M 
   
  ABinitN2m = VB*CBinitN2m/1000 
  ADinitN2m = ABinitN2m*k4N2M/k3N2M 
  APinitN2M = (k5N2M/k6N2M)*ABinitN2M 
   
  ABinitC10 = VB*CBinitC10/1000 
  ADinitC10 = ABinitC10*k4C10/k3C10 
  APinitC10 = (k5C10/k6C10)*ABinitC10 
   
  ABinitC11 = VB*CBinitC11/1000 
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  ADinitC11 = ABinitC11*k4C11/k3C11 
  APinitC11 = (k5C11/k6C11)*ABinitC11 
   
  ABinitC12 = VB*CBinitC12/1000 
  ADinitC12 = ABinitC12*k4C12/k3C12 
  APinitC12 = (k5C12/k6C12)*ABinitC12 
 
 
!-------Simulation parameters 
 
CONSTANT  TEXP = 240   ! Duration of exposure (min) 
CONSTANT  TSTOP = 7200   ! Duration of simulation (min) 
 POINTS = 7200    ! Number of times data are logged 
 CINT = TSTOP/POINTS   ! Communication intervals 
 
ALGORITHM IALG = 2      ! Use Gear integration algorithm  
 
END          ! End of initial section  
 
!----------------------------------------------------------------------------------------------------------------- 
 
DYNAMIC  ! Beginning of execution section 
 
DISCRETE CAT1    !Schedule events to turn exposure on and off daily 
   INTERVAL CAT = 1440.     !Set interval larger than any TSTOP(to prevent multiple 
exposure) 
    DERMDOSEN = MJP8N    
    DERMDOSEN1m = MJP8N1m    
    DERMDOSEN2m = MJP8N2m    
    DERMDOSEC10 = MJP8C10    
    DERMDOSEC11 = MJP8C11    
    DERMDOSEC12 = MJP8C12    
          
   SCHEDULE CAT2 .AT. T + TEXP    !Schedule end of exposure 
END      !End of CAT1 
 
DISCRETE CAT2 
       DERMDOSEN = 0.                 
       DERMDOSEN1m = 0.                
       DERMDOSEN2m = 0.                
       DERMDOSEC10 = 0.                 
       DERMDOSEC11 = 0.                 
       DERMDOSEC12 = 0.                 
 
END      !End of CAT2 
 
 
 
 
!----------------------------------------------------------------------------------------------------------------- 
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DERIVATIVE  ! Beginning of derivative definition block 
 
 
!-------------------------------------NAPHTHALENE----------------------------------------------------------------- 
 
!-----AXN = Amount of exposure 
  RAXN = k0N*DERMDOSEN 
   AXN = INTEG(RAXN,0.0) 
    
!-----ASN = Amount in skin (ug) 
  RASN = k0N*DERMDOSEN - k1N*ASN 
   ASN = INTEG(RASN,0.0) 
 
!-----ADN = Amount in deep skin (ug) 
 RADN = k1N*ASN - k2N*ADN + k3N*ABN 
  ADN = INTEG(RADN,ADinitN) 
 
!-----ABN = Amount in blood (ug) 
  RABN = k2N*ADN - k3N*ABN - k4N*ABN - k5N*ABN + k6N*APN 
   ABN = INTEG(RABN,ABinitN) 
   CBN = ABN/VB 
  CBVN = CBN*1000   ! Units are ng/ml 
   
  AUCN = INTEG(CBVN,0.0) 
 
!-----APN = Amount in peripheral (ug) 
  RAPN = k5N*ABN - k6N*APN 
   APN = INTEG(RAPN,APinitN) 
 
!-----ALN = Amount lost (ug) 
  RALN = k4N*ABN 
   ALN = INTEG(RALN,0.0) 
 
 
 
 
!-------------------------------------1-METHYL NAPHTHALENE------------------------------------------------------ 
 
!-----AXN1M = Amount of exposure 
  RAXN1M = k0N1M*DERMDOSEN1M 
   AXN1M = INTEG(RAXN1M,0.0) 
    
!-----ASN1M = Amount in skin (ug) 
  RASN1M = k0N1M*DERMDOSEN1M - k1N1M*ASN1M 
   ASN1M = INTEG(RASN1M,0.0) 
 
!-----ADN1M = Amount in deep skin (ug) 
 RADN1M = k1N1M*ASN1M - k2N1M*ADN1M + k3N1M*ABN1M 
  ADN1M = INTEG(RADN1M,ADinitN1M) 
 
!-----ABN1M = Amount in blood (ug) 
  RABN1M = k2N1M*ADN1M - k3N1M*ABN1M - k4N1M*ABN1M - k5N1M*ABN1M + 
k6N1M*APN1M 
   ABN1M = INTEG(RABN1M,ABinitN1M) 
   CBN1M = ABN1M/VB 
  CBVN1M = CBN1M*1000   ! Units are ng/ml 
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  AUCN1M = INTEG(CBVN1M,0.0) 
 
!-----APN1M = Amount in peripheral (ug) 
  RAPN1M = k5N1M*ABN1M - k6N1M*APN1M 
   APN1M = INTEG(RAPN1M,APinitN1M) 
 
!-----ALN1M = Amount lost (ug) 
  RALN1M = k4N1M*ABN1M 
   ALN1M = INTEG(RALN1M,0.0) 
 
 
 
    
!--------------------------------------2-METHYL NAPHTHALENE----------------------------------------------------- 
 
!-----AXN2M = Amount of exposure 
  RAXN2M = k0N2M*DERMDOSEN2M 
   AXN2M = INTEG(RAXN2M,0.0) 
    
 
!-----ASN2M = Amount in skin (ug) 
  RASN2M = k0N2M*DERMDOSEN2M - k1N2M*ASN2M 
   ASN2M = INTEG(RASN2M,0.0) 
 
!-----ADN2M = Amount in deep skin (ug) 
 RADN2M = k1N2M*ASN2M - k2N2M*ADN2M + k3N2M*ABN2M 
  ADN2M = INTEG(RADN2M,ADinitN2M) 
 
!-----ABN2M = Amount in blood (ug) 
  RABN2M = k2N2M*ADN2M - k3N2M*ABN2M - k4N2M*ABN2M - k5N2M*ABN2M + 
k6N2M*APN2M 
   ABN2M = INTEG(RABN2M,ABinitN2M) 
   CBN2M = ABN2M/VB 
  CBVN2M = CBN2M*1000   ! Units are ng/ml 
   
  AUCN2M = INTEG(CBVN2M,0.0) 
 
!-----APN2M = Amount in peripheral (ug) 
  RAPN2M = k5N2M*ABN2M - k6N2M*APN2M 
   APN2M = INTEG(RAPN2M,APinitN2M) 
 
!-----ALN2M = Amount lost (ug) 
  RALN2M = k4N2M*ABN2M 
   ALN2M = INTEG(RALN2M,0.0) 
 
 
 
    
!---------------------------------------DECANE----------------------------------------------------------------- 
 
!-----AXC10 = Amount of exposure 
  RAXC10 = k0C10*DERMDOSEC10 
   AXC10 = INTEG(RAXC10,0.0) 
    
!-----ASC10 = Amount in skin (ug) 
  RASC10 = k0C10*DERMDOSEC10 - k1C10*ASC10 
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   ASC10 = INTEG(RASC10,0.0) 
 
 
!-----ADC10 = Amount in deep skin (ug) 
 RADC10 = k1C10*ASC10 - k2C10*ADC10 + k3C10*ABC10 
  ADC10 = INTEG(RADC10,ADinitC10) 
 
!-----ABC10 = Amount in blood (ug) 
  RABC10 = k2C10*ADC10 - k3C10*ABC10 - k4C10*ABC10 - k5C10*ABC10 + 
k6C10*APC10 
   ABC10 = INTEG(RABC10,ABinitC10) 
   CBC10 = ABC10/VB 
  CBVC10 = CBC10*1000   ! Units are ng/ml 
   
  AUCC10 = INTEG(CBVC10,0.0) 
 
!-----APC10 = Amount in peripheral (ug) 
  RAPC10 = k5C10*ABC10 - k6C10*APC10 
   APC10 = INTEG(RAPC10,APinitC10) 
 
!-----ALC10 = Amount lost (ug) 
  RALC10 = k4C10*ABC10 
   ALC10 = INTEG(RALC10,0.0) 
 
 
 
 
!--------------------------------------UNDECANE--------------------------------------------------------------- 
 
!-----AXC11 = Amount of exposure 
  RAXC11 = k0C11*DERMDOSEC11 
   AXC11 = INTEG(RAXC11,0.0) 
    
!-----ASC11 = Amount in skin (ug) 
  RASC11 = k0C11*DERMDOSEC11 - k1C11*ASC11 
   ASC11 = INTEG(RASC11,0.0) 
 
!-----ADC11 = Amount in deep skin (ug) 
 RADC11 = k1C11*ASC11 - k2C11*ADC11 + k3C11*ABC11 
  ADC11 = INTEG(RADC11,ADinitC11) 
 
!-----ABC11 = Amount in blood (ug) 
  RABC11 = k2C11*ADC11 - k3C11*ABC11 - k4C11*ABC11 - k5C11*ABC11 + 
k6C11*APC11 
   ABC11 = INTEG(RABC11,ABinitC11) 
   CBC11 = ABC11/VB 
  CBVC11 = CBC11*1000   ! Units are ng/ml 
   
  AUCC11 = INTEG(CBVC11,0.0) 
 
!-----APC11 = Amount in peripheral (ug) 
  RAPC11 = k5C11*ABC11 - k6C11*APC11 
   APC11 = INTEG(RAPC11,APinitC11) 
 
!-----ALC11 = Amount lost (ug) 
  RALC11 = k4C11*ABC11 
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   ALC11 = INTEG(RALC11,0.0) 
 
    
!---------------------------------------DODECANE------------------------------------------------------------- 
 
!-----AXC12 = Amount of exposure 
  RAXC12 = k0C12*DERMDOSEC12 
   AXC12 = INTEG(RAXC12,0.0) 
    
!-----ASC12 = Amount in skin (ug) 
  RASC12 = k0C12*DERMDOSEC12 - k1C12*ASC12 
   ASC12 = INTEG(RASC12,0.0) 
 
!-----ADC12 = Amount in deep skin (ug) 
 RADC12 = k1C12*ASC12 - k2C12*ADC12 + k3C12*ABC12 
  ADC12 = INTEG(RADC12,ADinitC12) 
 
!-----ABC12 = Amount in blood (ug) 
  RABC12 = k2C12*ADC12 - k3C12*ABC12 - k4C12*ABC12 - k5C12*ABC12 + 
k6C12*APC12 
   ABC12 = INTEG(RABC12,ABinitC12) 
   CBC12 = ABC12/VB 
  CBVC12 = CBC12*1000   ! Units are ng/ml 
 
  AUCC12 = INTEG(CBVC12,0.0) 
 
!-----APC12 = Amount in peripheral (ug) 
  RAPC12 = k5C12*ABC12 - k6C12*APC12 
   APC12 = INTEG(RAPC12,APinitC12) 
 
!-----ALC12 = Amount lost (ug) 
  RALC12 = k4C12*ABC12 
   ALC12 = INTEG(RALC12,0.0) 
      
 
 
 
!--------------------------------------MASS BALANCE---------------------------------------------------------- 
 
!-----Mass balance  
  TMASSN = ASN + ADN + ABN + ALN + APN 
  MASSBALANCEN = TDOSEN - TMASSN 
  TDOSEN = AXN + ABinitN + ADinitN + APinitN 
 
  TMASSN1m = ASN1m + ADN1m + ABN1m + ALN1m + APN1M 
  MASSBALANCEN1m = TDOSEN1m - TMASSN1m 
  TDOSEN1m = AXN1m + ABinitN1m + ADinitN1m + APinitN1M 
   
 
  TMASSN2m = ASN2m + ADN2m + ABN2m + ALN2m + APN2M 
  MASSBALANCEN2m = TDOSEN2m - TMASSN2m 
  TDOSEN2m = AXN2m + ABinitN2m + ADinitN2m + APinitN2M 
   
  TMASSC10 = ASC10 + ADC10 + ABC10 + ALC10 + APC10 
  MASSBALANCEC10 = TDOSEC10 - TMASSC10 
  TDOSEC10 = AXC10 + ABinitC10 + ADinitC10 + APinitC10 
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  TMASSC11 = ASC11 + ADC11 + ABC11 + ALC11 + APC11 
  MASSBALANCEC11 = TDOSEC11 - TMASSC11 
  TDOSEC11 = AXC11 + ABinitC11 + ADinitC11 + APinitC11 
   
  TMASSC12 = ASC12 + ADC12 + ABC12 + ALC12 + APC12 
  MASSBALANCEC12 = TDOSEC12 - TMASSC12 
  TDOSEC12 = AXC12 + ABinitC12 + ADinitC12 + APinitC12 
 
 
 
 
TERMT(T.GE.TSTOP)      ! Condition for terminating simulation 
 
END       ! End of derivative block 
END       ! End of dynamic section 
END       ! End of program 
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APPENDIX C: 
PHYSIOLOGICALLY-BASED TOXICOKINETIC MODEL PROGRAM 
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PROGRAM: PBTKmanuscript3.CSL PHYSIOLOGICAL MODEL  
! PBTK model for inhalation and dermal exposure to NAPHTHALENE 
! Department of Environmental Sciences and Engineering, School of Public Health 
! The University of North Carolina at Chapel Hill 
! Constructed by David Kim beginning December 21, 2005 
 
INITIAL  
 
!Physiological Parameters *********************************** 
 
CONSTANT   HT = 178   ! Height (cm) 
CONSTANT      BW = 78         ! Body weight (kg) 
CONSTANT    AEXP = 21845.6   ! Surface area of exposure (cm^2) 
CONSTANT     QCC = 15      ! Cardiac output (L/hr-1kg) 
CONSTANT     QPC = 15      ! Alveolar ventilation (L/hr-1kg) 
CONSTANT     QEC = 0.05       ! Fractional blood flow to skin 
CONSTANT     QFC = 0.05       ! Fractional blood flow to fat 
CONSTANT     QLC = 0.23      ! Fractional blood flow to liver 
CONSTANT     VEC = 0.03       ! Fraction skin tissue 
 
 
!Skin parameters *************************************** 
 
CONSTANT     PERM1 = 0.00000045  ! Permeability coefficient through stratum corneum 
(cm/min) 
CONSTANT  PERM2 = 0.033  ! Permeability coefficient through viable  
epidermis (cm/min) 
CONSTANT  PD = 12.7   ! Partition coefficient of SC to VE 
CONSTANT  PE = 2.8      ! Skin/blood partition coefficient (VE to blood  
partition coefficient from McCarley and Bunge 2001) 
CONSTANT     TD = 0.001     ! Thickness of stratum corneum (cm) 
CONSTANT     TE = 0.03      ! Thickness of viable epidermis (cm) 
 
 
!Chemical specific parameters ******************************** 
 
CONSTANT      PB = 54.7      ! Blood/air partition coefficient 
CONSTANT      PF = 40.4      ! Fat/blood partition coefficient 
CONSTANT   PO = 4.2      ! Other/blood partition coefficient 
CONSTANT      MW = 128        ! Molecular weight (g/mol) 
 
 
!Metabolism parameters**************************************** 
 
CONSTANT   vmaxkm = 698        ! metabolic rate (L/min) 
 
 
!Calculated parameters *************************************** 
     HTM = HT/100    ! Height (m) 
      VB = (72.447/1000)*(BW**1.007)     ! Volume of blood (L) 
     BMI = BW/(HTM**2)    ! Body mass index (kg/m2) 
     FAT = -126.2 + 45*log(BMI)   ! Fat percent (%) 
   SURFA = (BW**0.45)*(HT**0.725)*71.84 ! Total body surface area (cm^2) by DuBois and 
DuBois (1916) 
 
      k0 = PERM1/Td    ! exposure to SC (1/min) 
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      k1 = (PERM2*AEXP/PD)/1000  ! SC to VE (L/min) 
 
    VECX = VEC*(AEXP/SURFA)     ! Fraction skin tissue exposed 
  VFC = FAT/100       ! Fraction fat tissue 
   VD = AEXP*TD/1000   ! volume of SC (L) 
 
      VE = VECX*BW - VD   ! Volume of viable epidermis - L 
   VF = VFC*BW                     ! Volume of fat - L 
      VO = 0.91*BW - VE - VF - VD  ! Other tissue volume - L 
        
   QC = (QCC*BW**0.75)/60         ! Cardiac output - L/min 
      QP = (QPC*BW**0.75)/60          ! Alveolar ventilation - L/min 
    
   QECX = QEC*(AEXP/SURFA)    ! Fractional blood flow to exposed skin 
      QE = QECX*QC          ! Exposed skin blood flow - L/min 
      QF = QFC*QC                      ! Fat blood flow - L/min 
      QO = QC - QF - QE    ! Other tissue blood flow - L/min 
   QL = QLC*QC 
    
   kmet1 = vmaxkm/(vmaxkm + QL)     ! extraction coefficient 
 
 
!Parameters for simulation of experiment ********************* 
 
CONSTANT   INHALCONC1 = 182.6   ! Concentration in air (ug/m^3) 
            INHALCIX1 = INHALCONC1/1000 ! Air concentration in ug/L 
  
CONSTANT   INHALCONC2 = 12.3    ! Concentration in air (ug/m^3) 
            INHALCIX2 = INHALCONC2/1000 ! Air concentration in ug/L 
 
CONSTANT    DJP8 = 0.00008   ! Mass per cm^2 of JP8 component on TS 
   MJP8 = DJP8*AEXP ! Mass of JP8 component on TS 
 
 
!Timing commands ********************************************* 
    
CONSTANT  TEXP = 229   ! Duration of exposure (min) 
CONSTANT TSTOP = 300   ! Duration of simulation (min) 
 POINTS = 300     ! Number of times data are logged 
   CINT = TSTOP/POINTS   ! Communication intervals 
 
ALGORITHM IALG = 2      ! Use Gear integration algorithm  
 
END          ! End of initial section  
          
    
DYNAMIC  
 
!--------------------------------------------------------- 
 
DISCRETE CAT1     ! Schedule events to turn exposure on and off daily 
INTERVAL CAT = 10000.0   ! Set interval larger than any TSTOP (to prevent 
multiple exposure) 
             CI = INHALCIX1           ! Start inhalation exposure 
       DERMDOSE = MJP8 
 
 106
   SCHEDULE CAT2 .AT. T + TEXP     ! Schedule end of exposure 
END       ! End of CAT1 
 
DISCRETE CAT2 
             CI = INHALCIX2            ! End inhalation exposure 
    DERMDOSE = 0.0   ! End dermal exposure  
END       ! End of CAT2 
 
!---------------------------------------------------------- 
 
 
DERIVATIVE  
 
!************************ NAPHTHALENE **************************** 
 
!AD = Amount in stratum corneum (ug) 
RAD = k0*DERMDOSE - k1*CD 
 AD = INTEG(RAD,0.0) 
 CD = AD/VD 
 
!AE = Amount in viable epidermis (ug) 
RAE = k1*CD + QE*(CV - CE/PE) 
AE = INTEG(RAE,0.0) 
CE = AE/VE 
       
!AF = Amount in fat tissue (ug) 
RAF = QF*(CV - CF/PF) 
AF = INTEG(RAF,0.0) 
CF = AF/VF 
    
!AO = Amount in other tissues (ug) 
RAO = QO*(CV - CO/PO) 
AO = INTEG(RAO,0.0) 
CO = AO/VO 
                                          
!CV = Venous blood concentration (ug/L) 
RAV = QP*CI + QE*CE/PE + QF*CF/PF + QO*CO/PO - QC*CV - QL*kmet1*CV - QP*CV/PB 
AV = INTEG(RAV,0.0) 
 CV = AV/VB 
    
 !AM = Amount metabolized (ug) 
 RAM = QL*kmet1*CV 
 AM = INTEG(RAM,0.0) 
     
 !AX = Amount exhaled (ug) 
RAX = QP*CX 
AX = INTEG(RAX,0.0) 
CX = CV/PB    ! units ug/L 
    
    CEX = CX*1000   ! units ug/m^3 
    AUCEX = INTEG(CEX,0.0) 
       
! MASS BALANCE NAPHTHALENE 
   
RINHALINPUT = QP*CI 
INHALINPUT = INTEG(RINHALINPUT,0.0) 
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RDERMALINPUT = k0*DERMDOSE 
 DERMALINPUT = INTEG(RDERMALINPUT,0.0) 
 
INPUT = INHALINPUT + DERMALINPUT 
   
! TMASS for Mass Balance (ug) 
  TMASS = AD + AE + AF + AO + AX + AM + AV 
 
MASSBALANCE = INPUT - TMASS 
 
 
TERMT(T.GE.TSTOP)  
       
END       ! End of derivative 
END       ! End of dynamic 
END       ! End of program 
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